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1. INTRODUCTION 
 
1.1. Drug delivery systems                                                                (Chien Y.W., 2009) 
 
 
The advancement of pharmacokinetics has established that the drug should be 
present above a certain minimum concentration in blood for as long a period as 
possible for optimum drug therapy. 
 
Although, continuous infusion has been recognized as a superior mode of drug 
administration to maintain a constant and prolonged rug level in the body such mode 
of administration entails certain risk and hence requires hospitalization of the patient 
and close supervision. 
 
As a result, solid oral dosage forms have become the most important and 
mostly used class of drug delivery system. Ordinary tablet and capsules known as 
conventional drug delivery system have to be administered several times a day 
depending on the biological half-life of the drug.  Such multiple dosing may reduce 
invariably high plasma level of drug leading to waste of costly drugs and patient non-
compliance. 
 
Two important features as important while developing as drug delivery 
system. i.e., it should deliver the drug at a rate dictated by the needs of the body over 
the entire period of treatment and the drug should solely reach the site of action. 
 
1.2. Sustained drug delivery systems                                            (Jain N.K.et al., 2004) 
 
 
The recognition of the fact that the absorption rate of the drugs into the body 
can be decreased by reduction of the rate of release of drug from the dosage forms.  It 
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leads to develop some system to release their medications to the body slowly for 
prolonged drug release and sustained drug action. 
 
Current efforts in the area of drug delivery include the development of targeted 
delivery in which the drug in only active in the body (for example, in cancerous 
tissues) and sustained release formulations which the drug is released over a period of 
time in a controlled manner form a formulation.  These of sustained release 
formulations include liposomes, drug loaded biodegradable microspheres and drug 
polymer conjugates. 
 
1.   Improve patient’s compliance and convenience due to less frequent dosing 
of drug. 
2.   Reduced ‘See-saw’ fluctuation and therefore helps in better control of 
disease condition. 
3.   Maximum   utilization   drug   enabling   reduction   in   total   amount   of   
dose administered. 
4.   Reduction in health care cost through improved therapy, shorter treatment 
period and less frequency of dosing. 
 
The problem frequently encountered is the is the increase the residence time 
of the dosage form in the stomach and proximal portion of the small intestine, due to 
the rapid gastrointestinal transit phenomenon of the stomach which may consequently 
diminish the extent of absorption of many drugs since almost most of the drug entities 
areMostly absorbed from the upper part of the intestine, therefore it would be 
beneficial to develop a sustained release formulation which remains at the absorption 
site for an extended period of time. 
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Several approaches have been immersed to prolong the residence time of the 
dosage forms at the absorption site and one of these is the development of oral 
bioadhesive/mucoadhesive system. Various gastrointestinal mucoadhesive dosage 
forms, such as discs, microspheres, and bilayered tablets, have been thoroughly 
prepared and reported by several research groups. 
 
1.3. Mucoadhesive drug delivery systems                         (Shoba rani R et al., 2008)       
Mucoadhesive drug delivery system is a new system of drug delivery and has 
recently gained great concern in pharmaceutical sciences.  The concept of 
mucoadhesives was introduced in the early 1980s. Mucoadhesion can be defined as 
the phenomenon of the attachment of natural or synthetic polymers to a mucosal 
surface. In general, the process involved in the mucoadhesion phenomenon can be 
described in three steps: first of all, the wetting and swelling of the polymer should 
allow an intimate contact with the tissue and secondly, interpenetration of the 
polymer chains and entanglement between the polymer and the mucin chains should 
be attained and finally, the formation of weak chemical bonds. Mucus is a 
viscous and heterogeneous biological product that coats many epithelial surfaces. 
Mucus-secreting cells are widely spread in different locations in the body, including 
the nasal, ocular, buccal area and the gastrointestinal, reproductive and respiratory 
tracts. Mainly, the mucus serves as a lubricant to minimize shear stresses and as a 
protection barrier against harmful substances. However, mucus can perform other 
important functions. Goblet cells located in the epithelium are unicellular mucus-
Secreting glands. Mucus is stored in large granules in the goblet cell and can be 
released by exocytosis or exfoliation of the whole cell. Mucus granules are mainly 
stored in the apical side of the goblet cell, which results in the characteristic balloon 
shape of these cells. Although the secretion of mucus can vary depending on age, sex, 
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body location and health  condition,  the  average  mucus  turnover  is  approximately  
6  h. Mucus  consists mainly of water (up to 95% weight), inorganic salts (about 
1% weight), carbohydrates and lipids (less than 1%) and glycoproteins (no more than 
5% weight). Mucus glycoproteins are also called mucins and consist of a protein core 
with branched oligosaccharide chains attached over 63% of its length. Approximately 
80% by weight of the glycoprotein consists of oligosaccharides, which make the 
mucin more hydrosoluble and also protects the protein core from proteolytic 
degradation. 
 
 
Figure 1.1: Mucus layer on epithelial surface 
 
Bioadhesives are natural polymeric materials that act as adhesives. The 
term is sometimes  used  more  loosely  to  describe  glue  formed  synthetically  from  
biological monomers  such  as  sugars,  or  to  mean  a  synthetic  material  designed  
to  adhere  to biological tissue. The term bioadhesion refers to any bond formed 
between two biological surfaces or a bond between a biological and a synthetic 
surface. It may be defined as attachment of synthetic biological macromolecules to a 
biological tissue. A more specific term than bioadhesion is mucoadhesion. 
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Mucoadhesion is the relatively new and emerging concept in drug delivery. 
Mucoadhesion is the special case of bioadhesion where the biological tissue is an 
epithelium covered by mucus. Most mucosal surfaces such as in the gut or nose are 
covered by a layer of mucus. 
Adhesion of a matter to this layer is hence called mucoadhesion. 
Mucoadhesion keeps the delivery system adhering to the mucus membrane. 
Mucoadhesion can be defined as the ability of synthetic or biological 
macromolecules to adhere to mucosal tissues. The concept of mucoadhesion is one 
that has the potential to improve the highly variable residence times experienced by 
drugs and dosage forms at various sites in the gastrointestinal tract, and consequently, 
to reduce variability and improve efficacy. 
These systems remain in close contact with the absorption tissue, the mucous 
membrane, releasing the drug at the site of action leading to an increase in 
bioavailability. 
Mucoadhesive drug delivery system prolong the residence time of the 
dosage form at the site of application or absorption and facilitate an intimate 
contact of the dosage form with the underline absorption surface and thus contribute 
to improved and / or better therapeutic performance of the drug. 
The mucoadhesive drug delivery system may include the following 
 
1. Buccal delivery system. 
 
2. Sublingual Delivery system. 
 
3. Vaginal delivery system. 
 
4. Rectal delivery system. 
 
5. Nasal delivery system. 
 
6. Ocular delivery system. 
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7. Gastro Intestinal delivery system 
 
        
 
 
                              Figure 1.2. Potential sites for mucosal drug delivery 
 
Their ability to stick to mucous membranes attracted attention as a pathway for 
resolving the problem of low bioavailability of traditional delivery systems used in 
the oral cavity and on the surface of the eye or other organs where movement of 
tissues or production of various secretions prevents prolonged retention of the 
medicinal agent. The reasons that the oral route achieved such popularity may be in 
part attributed to its ease of administration as well as the traditional belief that by oral 
administration the drug is well absorbed as the food stuffs that are ingested daily. 
In the exploration of oral controlled release drug administration, one encounters three 
areas of potential challenge. 
1. Development of a drug delivery system: To develop a viable oral controlled 
release drug delivery system capable of delivering a drug at a therapeutically effective 
rate to a desirable site for duration required for optimal treatment. 
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2. Modulation of gastro intestinal transit time: To modulate the GI transit time so 
that the drug delivery system developed can be transported to a target site or to the 
vicinity of an absorption site and reside there for prolonged period of time to 
maximize the delivery of a drug dose. 
3.  Minimization  of  hepatic  first  pass  elimination:  If  the  drug  to  be  delivered  
is subjected to extensive hepatic first pass elimination, preventive measures should be 
devised to either bypass or minimize the extent of hepatic metabolic effect. 
Definition of mucoadhesion                                             (Amit Alexander.et al., 2011) 
Adhesion can be defined as the bond produced by contact between a pressure - 
sensitive adhesive and a surface The American Society of testing and materials 
has defined it as the state in which two surfaces are held together by interfacial 
forces, which may consist of valence forces, interlocking action or both. When the 
adhesion involves    Mucus or mucus membrane it is termed as mucoadhesion. 
 
Concepts of mucoadhesion 
 
In biological systems, four types of bioadhesion can be distinguished as follows:- 
 
1. Adhesion of a normal cell on another normal cell. 
 
2. Adhesion of a cell with a foreign substance. 
 
3. Adhesion of a normal cell to a pathological cell. 
 
4. .Adhesion of an adhesive to a biological substance. 
 
Mucous membrane 
 
Mucous membranes are the moist linings of the orifices and internal parts of 
the body that are in continuity with the external surface. They cover, protect, and 
provide secretory and absorptive functions in the channels and extended pockets of the 
outside world that are incorporated in the body. Mucus is a translucent and 
viscid secretion, which forms a thin, continuous gel blanket adherent to mucosal 
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epithelial surface. The mean thickness of this layer varies from about 50-450 μm in 
humans. It is secreted by the goblet cells lining the epithelia or by special exocrine 
glands with mucus cells acini. The exact composition of the mucus layer varies 
substantially, depending on the species, the anatomical location and pathological 
states.  They secrete a viscous fluid known as mucus, which acts as a protective barrier 
and also lubricates the mucosal membrane. Mucosal membranes of human organism 
are relatively permeable and allow fast drug absorption they are characterized by an 
epithelial layer whose surface is covered by mucus.  The primary constituent of mucus 
is a glycoprotein known as mucin as well as water and inorganic salts. However, it has 
general composition. 
Table 1.1: Composition of Mucous Membrane 
 
S.NO. COMPOSITION % AMOUNT 
1 Water 95 
2 Glycoproteins and Lipids 0.5-5.0 
3 Mineral Salts 1 
4 Free Proteins 0.5-1.0 
+ 
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Table 1.2: Comparative properties of Gastrointestinal, Dermal andTransmucosal 
drug administration                                                                 (Khar R K. et al., 2002) 
 
 
 
Gastrointestinal 
 
Dermal 
 
Nasal 
Oral 
mucosal 
 
Vaginal 
Accessibility + +++ ++ ++ + 
Surface area +++ +++ + ++ +++ 
Surface Environment + ++ ++ +++ + 
Permeability +++ + +++ ++ +++ 
Reactivity ++ ++ + +++ ++ 
Vascular Drainage +++ + +++ ++ +++ 
First pass clearance + +++ +++ +++ + 
Patient acceptability ++ +++ ++ +++ +++ 
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Examples of mucosa 
 
 Buccal mucosa. 
 
 Oesophageal mucosa. 
 
 Gastric mucosa. 
 
 Intestinal mucosa. 
 
 Nasal mucosa. 
 
 Olfactory mucosa. 
 
 Oral mucosa. 
 
 Bronchial mucosa. 
 
 Uterine mucosa. 
 
 Endometrium (mucosa of the uterus). 
 
 Penile mucosa. 
 
1.4 Mucoadhesive polymers 
 
Mucoadhesive polymers are water-soluble and water-insoluble polymers, 
which are swellable networks, jointed by cross-linking agents. These polymers possess 
optimal polarity to make sure that they permit sufficient wetting by the mucus 
and optimal fluidity that permits the mutual adsorption and interpenetration of 
polymer and mucus to take place. 
Mucoadhesive polymers that adhere to the musin-epithelial surface can be 
conveniently divided into three broad classes, 
1) Polymers that become sticky when placed in water and owe their muco- 
adhesion to stickiness. 
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Biodegradable 
 
 
 
Poly (lactides), 
 
 
 
Poly (lactide-coglycolides), 
 
 
Poly caprolactones, 
 
Poly alkyl cyanoacrylates. 
 
 
Poly orthoesters, 
 
Poly (glycolides), 
 
 
Poly phosphoesters, 
 
Poly anhydrides, 
 
 
Poly phosphazenes, 
 
Chitosan, 
 
 
2) Polymers that adhere through nonspecific, noncovalent interactions are 
primarily electrostatic in nature (although hydrogen and hydrophobic bonding 
may be significant). 
3) Polymers that bind to specific receptor site on tile self 
surface. 
 
Examples of some Mucoadhesive polymer 
 
 
 
 
Natural /Semi-synthetic   Na alginate, 
Pectin, 
Xanthan gum, 
 
Agarose, 
Tragacanth, 
Carragenan, 
 
Chitosan, 
Gelatin, 
Starch 
 
 
Synthetic 
 
 
Poly vinyl alcohol, 
 
 
Polyamides, 
 
 
Polycarbonates, 
 
 
Poly alkylene glycols, 
 
Poly vinyl ethers, 
 
Esters and halides 
 
 
Poly methacrylic acid, 
 
PMMA, 
 
Methyl cellulose, 
 
 
Ethyl cellulose, 
 
HPC, 
 
HPMC 
 
 
Methyl cellulose, 
 
Sod. CMC  
 
 
Bicompatible          Esters of haluronic acid, 
polyvinyl acetate, 
Ethylene glycol. 
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Ideal characteristics of a mucoadhesive polymer 
 
1. The polymer and its degradation products should be nontoxic and 
nonabsorable from the GIT. 
2. It should be nonirritant to the mucous membrane. 
 
3. It should preferably form a strong noncovalent bond with the mucin-epithelial 
cell surfaces. 
4. It should adhere quickly to most tissue and should possess some site-specificity. 
 
5. It should allow daily incorporation to the drug and offer no hindrance 
to its release. 
6. The polymer must not decompose on storage or during the shelf life of the 
dosage form. 
7. The cost of polymer should not be high so that the prepared dosage form 
remains competitive. 
 
1.5. Factors affecting mucoadhesion 
 
1) Polymer Related Factors 
 
a) Molecular weight: The interpenetration of polymer molecules into the mucus 
layer is variable, for low molecular weight polymers penetration is more than high 
molecular weight polymers because entanglements are favored in high molecular 
weight polymers.  
b) Concentration of active polymer: For solid dosage forms such as tablets, the 
higher the concentration of polymer, the stronger the bioadhesion force. 
c) Spatial Conformation: Bioadhesive force is also dependent on the conformation 
of polymers, i.e., helical or linear. The helical conformation of polymers may shield 
many active  groups,  primarily  responsible  for  adhesion,  thus  reducing  
themucoadhesive strength of the polymer. 
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d) Chain flexibility of polymer: Chain flexibility is important for interpenetration 
and enlargement.  As  water-soluble  polymers  become  more  and  more  cross  
linked,  the mobility of the individual polymer chain decreases, also as the cross 
linking density increases, the effective length of the chain which can penetrate into 
mucus decrease even further and mucoadhesive strength is reduced. 
e) Degree of Hydration: Another important factor affecting the mucoadhesive 
strength of polymeric components is the degree of hydration. In this respect many 
polymers will exhibit adhesive properties under conditions where the amount of water 
is limited. However in such a situation, adhesion is thought to be a result of a 
combination of capillary attraction and osmotic forces between the dry polymer and 
the wet mucosal surface which act to dehydrate and strengthen the mucus layer. 
Although this kind of “sticking” has been referred to as mucoadhesion it is important 
to clearly distinguish such processes from “wet-on-wet” adhesion in which swollen 
mucoadhesive polymers attach to mucosal surfaces. Hydration is essential for the 
relaxation and interpenetration of polymer chains, excess hydration could lead to 
decreased mucoadhesion and/orientation due to the formation of slippery mucilage. 
In this situation cross linked polymers that only permit a certain degree of hydration 
may be advantageous for providing a prolonged mucoadhesive effect. The attachment 
and bonding of bioadhesive polymers to biological substrates occurs mainly through 
interpenetration followed by secondary non-covalent bonding between substrates. 
Given that secondary bonding mainly arises due to hydrogen bond formation, it is 
well accepted that mucoadhesive polymers possessing hydrophilic functional such 
as, carboxyl (COOH), hydroxyl (OH), amide (NH2) and sulphate groups (SO4H)  may  
be  more  favorable  in  formulating  targeted  drug  delivery  platforms. Typically,   
physical   entanglements   and   secondary   interactions   (hydrogen   bonds) 
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contribute to the formation of a strengthened network; therefore polymers that exhibit 
a high  density  of  available  hydrogen  bonding  groups  would  be  able  to  interact  
more strongly with mucin glycoproteins. 
2)Environmental–Related  Factors 
 
a) pH: pH influences the charge on the surface of both mucus and polymers. Mucus 
will have a different charge density depending on pH, because of difference in 
dissociation of functional groups on carbohydrate moiety and amino acids of the 
polypeptide backbone, which may affect adhesion. 
b) Applied strength: To place a solid bioadhesive system, it is necessary to apply a 
defined strength. Whichever the polymer may be the adhesion strength of those 
polymers increases with the increase in the applied strength. 
c) Initial contact time: The initial contact time between mucoadhesive and the mucus 
layer determines the extent of swelling and the interpenetration of polymer chains. 
The mucoadhesive strength increases as the initial contact time increases. 
d) Selection of the model substrate surface: The handling and treatment of 
biological substrates during the testing of mucoadhesive is an important factor, since 
physical and biological changes may occurs in the mucus gels or tissues under the 
experimental conditions. 
3) Swelling: The swelling characteristic is related to the polymer itself, and also to its 
environment. Interpenetration of chains is easier as polymer chains are disentangled 
and free of interactions. More the swelling of polymeric matrix higher the adhesion 
time of polymers. 
4) Physiological variables: Mucin turnover and disease state of mucus layer are 
physiological variables, which may affect bioadhesion. 
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Functions of mucous layer                                                       (Jain N.K.et al., 2004) 
The mucous layer, which covers the epithelial surface, has various roles. 
1. Protective Role. 
 
2. Barrier Role. 
 
3. Adhesion Role. 
 
4. Lubrication Role. 
  
5. Mucoadhesion Role. 
 
1. Protective Role: The Protective role results particularly from its hydrophobicity 
and protecting the mucosa from the lumen diffusion of hydrochloric acid from the 
lumen to the epithelial surface. 
2. Barrier Role: The role of mucus layer as barrier in tissue absorption of drugs 
and other substances is well known as it influence the bioavailibity of the drugs.The 
mucus constitutes  diffusion  barrier  for  molecules,  and  especially  against  drug  
absorption diffusion through mucus layer depends on molecule charge, hydration 
radius, ability to form hydrogen bonds and molecular weight 
3. Adhesion Role: Mucus has strong cohesive properties and firmly binds the 
epithelial cells surface as a continuous gel layer. 
4. Lubrication Role: An important role of the mucus layer is to keep the 
membrane moist. Continuous secretion of mucus from the goblet cells is necessary 
to compensate for the removal of the mucus layer due to digestion, bacterial 
degradation and solubilisation of mucin molecules 
5. Mucoadhesion Role: One of the most important factors for bioadhesion is tissue 
surface roughness. Adhesive joints may fail at relatively low applied stresses if cracks, 
air bubbles, voids, inclusions or other surface defects are present. Viscosity and 
wetting power are the most important factors for satisfactory bioadhesion. 
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At physiological pH, the mucus network may carry a significant negative charge 
because of the presence of sialic acid and sulphate residues and this high charge 
density due to negative charge contributes significantly to the bioadhesion. 
Need of mucoadhesive 
 
 Controlled release. 
 
 Target & localised drug delivery. 
 
 By pass first pass metabolism. 
 
 Avoidance of drug degradation. 
 
 Prolonged effect. 
 
 High drug flux through the absorbing tissue. 
 
 Reduction in fluctuation of steady state plasma level. 
 
o An  ideal  dosage  form  is  one,  which  attains  the  desired  
therapeutic concentration of drug in plasma and maintains constant for 
entire duration of treatment. This is possible through administration of 
a conventional dosage form in a particular dose and at particular 
frequency. In most cases, the dosing intervals much shorter than the 
half life of the drug resulting in a number  of limitations associated 
with such a conventional dosage form are as follows: 
 P o o r  patient compliance; increased chances of missing the dose of a 
drug with short half-life for which frequent administration is necessary. 
 A typical peak plasma concentration time profile is obtained which makes 
attainment of steady state condition difficult. 
 The  unavoidable  fluctuation  in  the  drug  concentration  may  lead  to  
under medication or over medication as the steady state concentration 
values fall or rise beyond in the therapeutic range. 
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 T h e  fluctuating drug levels may lead to precipitation of adverse effects 
especially of a drug with small therapeutic index whenever 
overmedication occurs 
Advantages of mucoadhesives                                  (Punitha S and Ganga S., 2010) 
 
• A  prolonged residence time at the site of drug action or absorption. 
 
• A localization of drug action of the delivery system at a given target site. 
 
• An increase in the drug concentration gradient due to the intense 
contact of particles with the mucosal. 
• A  direct  contact  with  intestinal  cells  that  is  the  first  step  before  
particle absorption. 
• Ease of administration. 
 
• Termination of therapy is easy.{except gastrointestinal} 
 
• Permits localization of drug to the oral cavity for a prolonged period of time. 
 
• Can be administered to unconscious patients. Except gastrointestinal} 
 
• Offers an excellent route, for the systemic delivery of drugs with high first 
pass metabolism, there by offering a greater bioavailability 
• A significant reduction in dose can be achieved there by reducing dose 
related side effects. 
• Drugs which are unstable in the acidic environment are destroyed by 
enzymatic or alkaline environment of intestine can be administered by this 
route. Eg. Buccal sublingual, vaginal. 
• Drugs which show poor bioavailability via the oral route can be 
administered conveniently. It offers a passive system of drug absorption 
and does not require any activation. 
• The  presence  of  saliva  ensures  relatively  large  amount  of  water  for  
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drug dissolution unlike in case of rectal and transdermal routes. 
• Systemic absorption is rapid. 
 
• This route provides an alternative for the administration of various 
hormones, narcotic analgesic, steroids, enzymes, cardiovascular agents etc. 
• The buccal mucosa is highly perfused with blood vessels and offers a 
greater permeability than the skin. 
• Less dosing frequency. 
• Shorter treatment period. 
• Increased safety margin of high potency drugs due to better control of 
plasma levels. 
• Maximum utilization of drug enabling reduction in total amount of drug 
administered. 
• Improved patient convenience and compliance due to less frequent drug 
administration. 
• Reduction in fluctuation in steady state levels and therefore better 
control of disease condition and reduced intensity of local or systemic side 
effects. 
• Despite the several advantages associated with oral controlled drug 
delivery systems, there are so many disadvantages, which are as follows: 
• Basic assumption is drug should absorbed throughout GI tract 
 
• Limited gastric residence time which ranges from few minutes to 12 hours 
which lead to unpredictable bioavailability and time to achieve maximum 
plasma level. 
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1.6. Limitations of mucoadhesion 
 
1. Drug administration via the buccal mucosa has certain limitations 
 
2. Drugs, which irritate the oral mucosa, have a bitter or unpleasant taste, 
odour, cannot be administered by this route. 
3. Drugs, which are unstable at buccal pH cannot be administered by this route. 
 
4. Only drugs with small dose requirements can be administered. 
 
5. Drugs may swallow with saliva and loses the advantages of buccal route. 
 
6. Only those drugs, which are absorbed by passive diffusion, can be 
administered by this rout. 
7. Eating and drinking may become restricted. 
 
8. Swallowing of the formulation by the patient may be possible. 
 
9. Over  hydration  may  lead  to  the  formation  of  slippery  surface  and  
structural integrity of theformulation may get disrupted by the swelling and 
hydration of the bioadhesive polymers. 
 
1.7. Stages of mucoadhesion                                                                (Vyas .S. P.,2002) 
 
1. Contact Stage 
 
2. Consolidation Stage. 
 
Contact Stage: The first stage is characterized by the contact between the 
mucoadhesive and the mucous membrane, with spreading and swelling of the 
formulation, initiating its deep contact with the mucus layer. 
Consolidation Stage: In the consolidation step (Figure 1), the mucoadhesive 
materials are activated by the presence of moisture. Moisture plasticizes the 
system, allowing the mucoadhesive molecules to break free and to link up by 
weak Vander Waals and hydrogen bonds. 
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Figure 1.3: The two steps of the mucoadhesion process 
 
 
 
1.8. Theories of mucoadhesion                                                    (Jain N.K. et al., 2004) 
 
1. Electronic Theory 
 
The   adhesive   polymer   and   mucus   membrane   strategically   have   
different electronic characteristics. When the two surfaces contact each other, a double 
layer of electrical charge is formed at the interface, and then adhesion developed 
between the double layers due to electrical charge. 
2. Adsorption Theory 
 
The adsorption theory of bioadhesion proposes two bond theories: 
 
(i) Primary chemical bonds permanent and therefore undesirable in bioadhesion 
 
(ii) Secondary chemical bonds are found to be van-der Waals, hydrogen, 
hydrophobic and electrostatic forces. 
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3. Wetting Theory 
 
The wetting theory emphasizes mainly on the intimate contact between the 
adhesive and mucus. Thus, a wetting surface will be controlled by structural similarity, 
degree of cross linking of the adhesive polymer, or use of a surfactant. 
4. Diffusion Theory 
 
A semi permanent adhesive bond is formed because of the chains of adhesive 
and the substrate interpenetrates one another to a sufficient depth and it is considered 
as the essence of this theory. The diffusion coefficient of both interacting polymers 
and the diffusion co-efficient are the factors responsible for the penetration rate. In 
addition mobility, flexibility of the bioadhesive polymer, mucus glycoprotein, and the 
expanded nature of both network are other important parameters considered.
Mucoadhesive microspheres of Metronidazole Introduction 
 
Adhiparasakthi College of Pharmacy, Melmaruvathur. Page 22 
 
1.9. Mechanism of mucoadhesion                                            (Bhatt j.h..et al.,2009)                                  
The concept of mucoadhesion is one that has the potential to improve the highly 
variable residence times experienced by drugs and dosage forms at various sites in 
the gastrointestinal  tract,  and  consequently,  to  reduce  variability  and  improve  
efficacy.Intimate contact with the mucosa should enhance absorption. The 
mechanisms responsible in the formation of bioadhesive bonds are not fully known, 
however most research has described bioadhesive bond formation as a three step 
process. 
 
 
 
Figure 1.4:  Interaction of mucoadhesive drug delivery system with mucous layer 
 
STEP 1: Wetting and swelling of polymer 
 
STEP 2: Interpenetration between the polymer chains and the mucosal membrane. 
 
STEP 3: Formation of Chemical bonds between the entangled chains. 
 
Step 1 
 
The wetting and swelling step occurs when the polymer spreads over the 
surface of the biological substrate or mucosal membrane in order to develop an 
intimate contact with the substrate. 
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This can be readily achieved for example by placing a bioadhesive formulation 
such as a tablet or paste within the oral cavity or vagina. Bioadhesives are able to 
adhere to or bond with biological tissues by the help of the surface tension and 
forces that exist at the site of adsorption or contact. Swelling of polymers occurs 
because the components within the polymers have an affinity for water. 
 
 
 
 
Figure 1.5: Wetting and Swelling of Polymer 
 
 
 
 
      Step 2 
 
The surface of mucosal membranes is composed of high molecular weight 
polymers known as glycoproteins. In this step interdiffusion and interpenetration take 
place between the chains of mucoadhesive polymers and the mucous gel network 
creating a great area of contact. The strength of these bonds depends on the degree of 
penetration between the two polymer groups. In order to form strong adhesive 
bonds,onepolymer
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Group must be soluble in the other and both polymer types must be of similar chemical 
structure. 
Interdiffusion and 
interpenetration 
 
 
 
 
              Figure 1.6: Interdiffusion and Interpenetration of Polymer and Mucus 
 
      Step 3 
 
In this step entanglement and formation of weak chemical bonds as well as 
secondary bonds between the polymer chains mucin molecule The types of bonding 
formed between the chains include primary bonds such as covalent bonds and weaker 
secondary interactions such as van-der Waals Interactions and hydrogen bonds. 
Both
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primary  and  secondary  bonds  are  exploited  in  the  manufacture  of  bioadhesive 
formulations in which strong adhesions between polymers are formed. 
 
 
      
 
Figure.1.7: Entanglement of Polymer and Mucus by Chemical bonds 
 
1) Ionic bonds—where two oppositely charged ions attract each other via electrostatic 
interactions to form a strong bond (e.g. in a salt crystal). 
2) Covalent bonds—where electrons are shared, in pairs, between the bonded atoms in 
order to fill the orbital in both. These are also strong bonds. 
3) Hydrogen bonds—here a hydrogen atom, when covalently bonded to electronegative 
atoms such as oxygen, fluorine or nitrogen, carries a slight positively charge and is 
therefore is attracted to other electronegative atoms.  The hydrogen can therefore be 
thought of as being shared, and the bond formed is generally weaker than ionic or 
covalent bonds. 
4) Van-der-Waals bonds—these are some of the weakest forms of interaction that arise 
from dipole– dipole and dipole-induced dipole attractions in polar molecules, and 
dispersion forces with non-polar substances. 
5) Hydrophobic bonds—more accurately described as the hydrophobic effect, these are 
indirect bonds (such groups only appear to be attracted to each other) that occur when 
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non-polar groups are present in an aqueous solution. Water molecules adjacent to non- 
 
polar groups form hydrogen bonded structures, which lowers the system entropy. 
 
Micro particles are of two types                                             (Khar R K. et al., 2002) 
 
1. Microspheres: The adsorbed substance is dispersed through out the microsphere matrix 
2. Micrcapsules: The entrapped substance is completely surrounded by a distinct capsule 
wall 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: Differentiation between microspheres and microcapsules 
 
1.10. Loading of drug 
 
 
The active components are loaded on to the microspheres principally using two 
 
methods either during the preparation or after the formation of microsphere by incubating 
 
them with drug. 
 
The active components can be loaded by means of physical entrapment, chemical 
 
Linkage or surface absorption.  Entrapment largely depends on the method of preparation 
 
And the nature of drug and polymer. 
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Maximum loading can be achieved by incorporating the drug at the time of 
preparation but it may get affected by many other process variables such as method of 
preparation, presence of additives heat of polymerization, agitation intensity etc.  drug 
in loading in pre-formed microspheres is relatively less but the major advantage of the 
loading method is that there is no effect of process variables, loading is carried out in 
preformed microsphere by incubating them with high concentration of drug in a 
suitable solvent.  The drug in these microspheres is loaded by penetration or diffusion 
through the pores. 
 
 
 
 
Figure 1.9: Different methods employed for microspheres 
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1.11. Methodology                                                               (Shoba rani R. et al.,2008) 
 
 
The selected methods of Mucoadhesive microspheres was prepared by, 
 
 
Ionic Orifice Gelation Technique 
 
 
In this technique cross linking was done with calcium chloride solution to 
release the drug in a controlled manner.    Microspheres were prepared by using  
Orifice ionic gelation technique in which sodium alginate, HPMC and M etylcellulose 
in different ratios as mentioned above was added to 32 ml of water  the above solution 
with continuous stirring to form homogenous solution. 
 
After the  solution by sonicating the mixture for 20 minutes the Metronidazole 
was then added to the above solution to form a clear solution.   The drug polymer 
mixture is  poured in 1.5% calcium chloride solution by using 22# needle by stirring 
at 50rpm the microspheres thus formed are allowed 30 min for curing in calcium 
chloride solution then were decanted and washed with distilled water and air dried 
over night at room temperature. 
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Figure 1.10: Beads prepared by the ionic orifice gelation method 
 
 
1.12.Techniques to manufacture microspheres 
 
A.physical methods 
 
Air-suspension coating 
 
                            The particles are coated while suspended in an upward-moving air flow 
stream.just sufficient air is only permitted to rise through the outer annular space to fluidie the 
particles settling most of the rising air (usually heated) flows inside around the cylinder causing 
the particles rising rapidly. 
                     At the top surface, as the air stream diverges and slows,they settle back on to the 
outer bed and move down ward to repeat the cycle.in this process,as ability of applying coatings 
in the form of solvent solutions,aqueous solution,emulsions,and dispersions.core materials 
comprised of micron particles can be effectively encaps lated by air suspension techiniques,but 
agglomeration of the particles to some larger size is achieved.  
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     Coacervation-Phase Separation 
 
The general outline of the processes consists of three steps carried out under 
continuous agitation. 
1. Formation of three immiscible chemical phases 
 
A liquid manufacturing phase, a core material and a coating material. To form 
the three phases, the core material dispersed in a solution of the coating polymer, the 
solvent for the polymer being the liquid manufacturing vehicle phase. 
2. Deposition of the coating 
 
It is mainly of depositing the liquid polymer coating upon the core material. 
This is obtained by controlled, physical mixing of the material in the manufacturing 
vehicle. Deposition of the liquid polymer coating around the core material occurs only 
if the polymer is adsorbed at the interface between the core material and the liquid 
vehicle phase. The continued deposition of the coating material is improved by a 
reduction in the total free interfacial energy of the system. 
3. Rigidization of the coating 
 
It involves mainly in rigidizing the coating, usually by thermal, cross-linking, 
or desolvation techniques, to form a self-sustaining microspheres. 
Pan coating 
 
The pan coating process, mainly used in the pharmaceutical industry, is 
among the  oldest  industrial  procedures  for  forming  small,  coated  particles  or  
tablets.  The particles are mainly tumbled in a pan or other device while the coating 
material is applied steadily and slowly. The particles has been tumbled in pan, while 
the coating material is applied slowly with respect to microspheres, solid particles are 
greater. 
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Figure 1.11: Pan coating and its process 
 
Spray–drying 
 
Spray drying is an important microspheres technique in this an active material 
is dissolved or suspended in a melt or polymer solution and becomes trapped in the 
dried particle. The main advantages of this ability to handle labile materials 
because of the short contact time in the dryer, in addition, the operation is 
economical. In modern spray dryers, the solutions are to be sprayed can be as high 
as 300mPa.s. Spray drying and spray congealing processes are similar in that both 
involve dispersing the core material in a liquid coating substance and spraying the core 
- coating mixture into some environmental condition, whereby relatively rapid 
solidification (and formation) of the coating is affected. The principal difference 
between the two methods is the coating solidification is obtained. 
Coating solidification in the case of spray drying is effected by rapid 
evaporation of a solvent, by thermally congealing a molten coating material or by 
solidifying a dissolved coating by introducing the coating - core material mixture 
into a non-solvent. 
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Removal of the non-solvent or solvent from the coated product is then accomplished 
by sorption, extraction, or evaporation techniques. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12: Spray drying technique and its process 
 
 
 
 
Chemical process 
 
Solvent Evaporation 
 
The liquid manufacturing vehicle is the mainly used for the formulation. The 
coating for the microspheres will be dissolved in a volatile solvent, which has to be 
immiscible with the liquid manufacturing vehicle phase. A core material will be either 
dissolved or dispersed in the coating polymer solution. On agitation, the core coating 
material mixture will be dispersed in the liquid manufacturing vehicle phase to obtain 
the microspheres of appropriate size. The mixture will be then heated (if necessary) to 
evaporate the solvent in the polymer. In the case in which the core material is 
dispersed in the polymer solution, polymer shrinks around the core. 
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In the case in which core material is dissolved in the coating polymer solution, 
a matrix - type microsphere is formed. Once all the solvent evaporated, the liquid 
vehicle temperature is reduced to ambient temperature (if required) with continued 
agitation. At this stage, the microspheres can also be used in suspension form, coated 
on to substrates or isolated as powders. 
 
 
 
 
 
Figure 1.13: Solvent evaporation process 
 
The solvent evaporation technique is used to produce microspheres which are 
applicable to a wide variety of liquid and solid core materials. The core materials may 
be either water - soluble or water - insoluble materials. e.g. “Evaluation of Sucrose 
Esters as Alternative Surfactants in Microspheres of Proteins by the Solvent 
Evaporation Method”.  
Centrifugal extrusion 
Liquids are been encapsulated using a rotating extrusion head containing 
concentric nozzles. In this particular process, a core liquid is surrounded by a sheath of 
wall solution or melt. As the jet moves through the air it will break, owing to Rayleigh 
instability,  core  droplets  are  formed,  each  coated  with  the  wall  solution.  From 
the droplets formed, a molten wall will be hardened or a solvent may be evaporated 
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from the wall solution. This process is excellent for forming making particles 400–
2,000 μm (16–79 mils) in diameter. 
 
Vibrational Nozzle 
 
 
Micro granulation (matrix-encapsulation) can be done by using a laminar flow 
through a nozzle and an additional vibration of the nozzle. The vibration has to be 
done in resonance and Rayleigh instability leads to form uniform droplets. The 
liquid should be with limited viscosities (0-10,000 mPa·s have been shown to work), 
e.g. solutions, emulsions, suspensions, melts etc.  The solidification can be done with 
an internal gelation (e.g. sol-gel processing, melt) or an external (additional binder 
system, e.g. in a slurry). The process works for generating droplets between 100–
5,000 µm (3.9–200 mils), for preparing smaller and larger droplets are known. 
 
Inter facial polymerization 
 
In Interfacial polymerization, polycondensation of the two reactants occur in 
between. The basis of this method termed as the classical Schotten-Baumann reaction 
between compound an acid chloride containing an active hydrogen atom, such as 
an amine or alcohol, polyesters, polyurea, polyurethane. 
 
       Matrix polymerization 
 
 
In this method, the particle is formed by evaporation of the solvent from 
the matrix material.  However,  the  solidification  of  the  matrix  also  can  be  caused  
by  a chemical change in a number of processes; a core material is dissolved in a 
polymeric matrix during formation of the particles. A simple example of this kind is 
actually Spray Drying method, in which the particle is formed by evaporation of 
the solvent from theMatrix material. However the chemical change can also cause 
solidification of materials. 
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1.13. Release kinetics patterns of microspheres 
 
Although, the aim of the microsphere is to protect the core by surrounding wall. The 
wall may get ruptured at the time of usage. microsphere contents may get ruptured by 
melting the wall, dissolving it under particular conditions , as in the case of  an enteric 
coating , in other system it get ruptured by solvent action , enzyme action. 
Micro sphere can be used to slow the release of a drug into the body. This may 
help for the controlled release dose to substitute for several doses of non-encapsulated drug 
and also may decrease toxic side effects for some drugs by preventing high initial 
concentrations in the blood. 
1.14. Applications of microspheres                                                      (Jain N. K.et al., 2004) 
 
1.   Microspheres in vaccine delivery. 
 
2.   Targeting using micro particulate carriers  
           a.   Targeting may be provided by: 
b.   By controlling the size of the microspheres  
c.   By conjugation with antibodies 
d.   By incorporation of magnet particle 
 
3.   Monoclonal antibodies mediated microspheres targeting 
 
4.   Chemo embolisation 
 
5.   Imaging 
 
6.   Topical porous microspheres 
 
7.   Surface modified microspheres
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2. LITERATURE SURVEY 
 
Literature review indicating advancement in Microsphere drug delivery system is given by: 
Akanksha Garud., et al.(2010)  Metronidazole microcapsules with a coat consisting of alginate 
and the natural cationic polymer, chitosan were formulated by using tripolyphosphate cross-linking 
method and were investigated with a view to develop mucoadhesive microcapsules. The 
microcapsules were evaluated for their surface morphology, microencapsulation efficiency, in-vitro 
wash-off test, swelling behavior and in-vitro drug release. The microcapsules formed had rough 
surface morphology in scanning electron microscopy. The drug entrapment efficiency was found to 
be in the range 75.2±1.31% and 82.1±0.75%. Chitosan microcapsules displayed a limited amount 
of swelling which is supposed to be related to the degree of cross-linking with tripolyphosphate. 
The microcapsules showed better mucoadhesive property at intestinal pH 7.4 than at gastric pH 1.2 
in the in-vitro wash-off test. The drug release was found to be slow and extended over long 
duration of time. 
 
  Bhatt jh., et al. (2009) were prepared Metronidazole Microsphere employing sodium alginate 
in combination with four mucoadhesive polymers – sodium CMC, Methylcellulose, Carbopol 
and HPMC-K4M as coat materials with different polymers ratios. The microspheres were found 
to discrete, spherical, free flowing, and of the monolithic matrix type. The mucoadhesive 
microspheres were evaluated by in vitro and in vivo methods using Gamma Scintigraphy for 
controlled release. 
 
Devraj., et al. (2010)   present article deals with an oral dosage form proposed for the attainment of 
timed release drug delivery of metronidazole. Metronidazole containing matrix tablets coated with 
3,4,5 & 6% w/v cellulose acetate phthalate in acetone were examined for applicability as timed 
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release tablets with a predetermined lag time of 4-5 hrs. Different types of enteric coated tablets 
were prepared and there drug dissolution profile was studied in 0.1 N HCl (0 to 2hr) and PBS 6.8 
(2-24 hr) as dissolution media at 37±0.5 ºC,100 rpm by USP Apparatus-1(Basket assembly). The 
result indicated that the tablets with timed release functions could be prepared and,that the lag time 
were increased as the coat concentrations increased (3% to 6%w/v).The different kinds of timed 
release enteric coated tablets that showed lag time of 2 to 5.4 hrs in in- vitro dissolution in 2% w/v 
rat caecal content in 6.8 PBS(Phosphate buffer saline). The lag time showed a good agreement 
between the in- vitro test in PBS 6.8 and in -vitro test in 2% w/v rat caecal content. However the 
lag times were 4.5 hrs in in-vitro test in 2%w/v rat caecal content medium. 
 
 Gupta AK .,  et al. (2011)   The aim of current work to develop and evaluate sustained release 
mucoadhesive (SRM) microspheres of Repaglinide using emulsification solvent evaporation 
technique. Effects of formulation variables i.e. polymer concentration and phase volume ratio on 
particle size, % mucoadhesion and drug release were investigated in this study. Scanning electron 
microscopy of microspheres with maximum drug content (FormulationCH1:8) demonstrated 
smooth surface spherical particles with mean diameter of 64.78 ± 3.26 μm. The mean Particle size, 
% drug loading and mucoadhesion were found to vary by changing the formulation               
variables. Microspheres size was significantly increased as increasing the polymer concentration in 
the aqueous phase while size of microspheres decrease as increase in volume of continuous phase. 
Decrease in size of microspheres leads to decrease in mucoadhesion time, % drug loading and 
faster the drug release. It can be concluded that the present mucoadhesive microspheres can be an 
ideal system to deliver the Repaglinide in sustained release manner for management of Type II 
Diabetes Mellitus. 
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 Madhavi Boddupalli B., et al. (2010) was to formulated and evaluated mucoadhesive    
microsphers of Venlafaxine Hydrochloride by using carbopol and HPMC K4M as mucoadhesive 
polymers. There was sustained release up to 12 hours and almost 70% of mucoadhesion was 
observed after 12 hours. The results were encouraging and further studies are required for in-
vivo efficiency. 
 
 Malay Das K., et al. (2008) were developed of diltiazem-loaded mucoadhesive microspheres 
successfully prepared by emulsification-internal gelation technique using different polymers. The 
scanning electron microscopic study indicated that the microspheres were spherical in shape. The 
in vitro wash-off test indicated that the microspheres had good mucoadhesive properties. The 
wash-off was faster at simulated intestinal fluid (phosphate buffer, pH 7.4) than that at 
simulated gastric fluid (0.1 M HCl, pH  1.2).  The  in  vitro  drug  release  mechanism  was  non-
fickian  type  controlled  by swelling and relaxation of polymer. 
 
 Mahendra Singh., et al. (2011) had prepared by emulsion cross linking method using 
Glutaradehyde as a cross linking agent. Gelatin A and Chitosan were used as polymer and co 
polymer respectively. All the prepared microspheres were evaluated for physical characteristics, 
such as particle size, incorporation efficiency, swelling index, in vitro bioadhesion using rat 
jejunum and in vitro drug release in pH 6.6 phosphate buffer. The data indicates the verapamil 
hydrochloride release followed Higuchi’s matrix and Peppas model. Stability studies showed 
stability of formulation at all the conditions to which the formulations were subjected. 
 
Nagda Chirag., et al. (2009) were designed, characterized and evaluated bioadhesive 
microspheres of ACE employing polycarbophil as bioadhesive polymer. Bioadhesive   
microspheres   of   ACE   were   prepared   by   double   emulsion   solvent evaporation method. 
The in-vitro release studies were performed using pH 6.8 phosphate buffer. The drug loaded 
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microspheres in a ratio of 1:5 showed 38 % of drug entrapment, percentage mucoadhesion was 
79 % and 89 % release in 10 h. The in vitro release profiles from microspheres of different 
polymer-drug ratios followed Higuchi model. 
 
Nishanth Kumar N., et al. (2011) was formulated and evaluated gliclazide mucoadhesive 
microsphere using hydroxypropylmethylcellulose K4M and carboxymethylcellulose as polymers 
were prepared by simple emulsification phase separation technique using glutaraldehyde as 
across-linking agent. Twenty preliminary trial batches, F1 to F20 batches of microspheres were 
prepared by using different volume of cross-linking agent, cross-linking time and 3:1 polymer-
to-drug ratio. Among the two polymers, the best batch was hydroxypropylmethylcellulose K4M 
exhibited a high drug entrapment efficiency of 69% and a swelling index1.16 % mucoadhesive 
after 1hour  was 70% and the drug release was also sustained for more than 10 h. 
 
Ofokansi KC., et al.(2007) had formulated ceftriaxone sodium-loaded mucoadhesive 
microspheres by the emulsification cross-linking method using arachis oil as the continuous 
phase. The release profile of ceftriaxone sodium from the microspheres was  evaluated  in  both  
simulated  gastric  fluid  (SGF)  without  pepsin  (pH  1.2)  and simulated intestinal fluid (SIF) 
without pancreatin (pH 7.4). Release of microspheres by diffusion following non-Fickian 
transport mechanism and was higher and more rapid in SIF than in SGF. The results obtained 
from this study may indicate that ceftriaxone sodium could be successfully delivered rectally 
when embedded in microspheres formulated with either type a gelatin alone or its admixtures 
with porcine mucin. 
 
 Patil P.B., et al. (2009) Mucoadhesive microspheres were prepared by an inter polymer 
complexation poly(acrylic acid) (PAA) with poly(vinyl pyrrolidone) (PVP) to increase gastric 
residence time and a solvent diffusion method. The complexation between poly(acrylic acid) and 
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poly(vinyl pyrrolidone) as a result of hydrogen bonding wasconfirmed by the shift in the 
carbonyl absorption bands of poly(acrylic acid) using FT-IR. A mixture of ethanol/water was 
used as the internal phase, corn oil was used as the external phase of emulsion, and span 80 was 
used as the surfactant. Spherical microspheres were prepared. Theparticle size increased as the 
content of water was increased. The mean particle size increased with the increase in polymer 
concentration. The adhesive force ofmicrospheres was equivalent to that of Carbopol. The 
release rate of atenolol from the complex microspheres was slower than the PVP microspheres at 
pH 2.0 and 6.8. 
 
 Rajeshwar kamal kant ., et al. (2010) had characterized of mucoadhesive microspheres with 
Famotidine as model drug for prolongation of gastric residence time Using mucoadhesive 
polymers sodium CMC and sodium alginate. In vitro drug release studies were performed and 
drug release evaluated. The prepared microspheres exhibited prolonged drug release (8h). The In 
vitro studies demonstrated diffusion-controlled drug release from the microspheres. 
 
 Ram Chand Dhakar., et  al.  (2010)   were   prepared   and   evaluated   by emulsification 
solvent evaporation method using Sodium carboxy methyl cellulose (SCMC), Carbopol 934P 
(CP), and Hydroxyl propyl methyl cellulose K4M (HPMC) as a mucoadhesive polymers. 
Microspheres prepared were found discrete, spherical and free flowing. Among all the 
formulation, formulation F1 containing SCMC and F2 containing CP showed the best 
reproducible results and mucoadhesive profile with good surface morphology. 
 
 Sambathkumar  R., et al. (2011) had formulated and systematically evaluated in vitro 
performances of Furazolidone mucoadhesive microspheres were prepared by simple 
emulsification phase separation technique using Eudragit RS100 as matrix and Carbopol 974P 
and Hydroxy propyl methyl cellulose K4M as mucoadhesive polymer. The prepared 
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microspheres were evaluated with respect to the particle size, encapsulation efficiency, shape and 
surface properties, mucoadhesive property, in vitro drug release and suitability for anti 
Helicobacter pylori effect. The best batch exhibited a high drug entrapment efficiency of 82.12 
% and percentage mucoadhesion after 1 h was 93.35 %. The drug release was also sustained up 
to 12 h. 
 
Senthil A., et al. (2011) were prepared by glipizide microspheres containing chitosan  simple  
emulsification  phase  separation  technique  using  glutaraldehyde  as  a cross-linking agent. 
Microspheres were discrete, spherical, and free flowing. The microspheres exhibited good 
mucoadhesive property in the in vitro wash-off test and also showed high percentage drug 
entrapment efficiency. A 32 full factorial design was employed to study the effect of 
independent variables, polymer-to-drug ratio (X1), and stirring  speed  (X2)  on  dependent  
variables  percentage  mucoadhesion,  t80,  drug entrapment efficiency, and swelling index. 
Percentage mucoadhesion after 1 hour was 78%. The drug release was also sustained for more 
than 12 hours. 
 
Saravanakumar K., et al. (2011) were formulated and developed of naproxen sodium 
microsphere two investigated factors (independent variables) were the stabilizer agent 
concentration in the aqueous phase (%w/v PVA) and the polymer concentration in the organic 
phase (%w/v HPMC K15M).The results showed that encapsulation efficiency was significantly 
affected by the two investigated factors, with PVA concentration having a highly negative 
effect, probably due to naproxen sodium’s solubility enhancement in the aqueous phase in the 
presence of higher amounts of stabilizer. These results demonstrate that it is possible to control 
the quantity of drug loaded in the microspheres. 
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Shiv   Shankar   Hardenia.,   et   al.   (2011)   were   prepared   and   evaluated ethylcellulose 
microspheres containing ciprofloxacin for in-vitro performance of ciprofloxacin. Ciprofloxacin 
microspheres containing ethylcellulose were prepared by emulsion  solvent  diffusion  
evaporation  method.  The  best  cumulative  release  was achieved after 24 hrs i.e. 91.6%. The 
Mucoadhesive property of the ethylcellulose microspheres was evaluated by in-vitro wash off 
test. The microspheres exhibited 75% mucoadhesion and showed good drug entrapment 
efficiency. By, above results it was concluded that ethylcellulose microspheres showed 
reproducible results, with good Mucoadhesive properties and good surface morphology. 
 
Venkateswaramurthy N., et al. (2010) was to designed and characterized mucoadhesive 
microspheres containing Clarithromycin as an anti‐H. pylori agent to deliver the drug specifically 
to mucus layer where H.pylori resides and evaluate the effectiveness of the mucoadhesive 
microspheres for H. pylori eradication therapy. Microspheres were prepared by using Eudragit 
RL100 as matrix and Carbopol 974P as a mucoadhesive   polymer.   The   microspheres   were   
prepared   by   emulsion   solvent evaporation technique. The prepared microspheres were 
evaluated with respect to the particle size, production yield, encapsulation efficiency, shape and 
surface properties, mucoadhesive property, in vitro drug release and suitability for anti 
Helicobactorpylori effect. 
 
 
  
Veena Belgamwar., et al. (2009) was to prepared and evaluated mucoadhesive multiparticulate   
system   for   oral   drug   delivery   using   ionic   gelation   technique. Microspheres composed 
of various mucoadhesive polymers including HPMC of various grades like K4M, K15M, 
K100M, E50LV, Carbopol of grades 971P, 974P and polycarbophil were prepared. In this 
technique cross linking of sodium alginate with calcium chloride was done which retarded the 
release of drug from the mucoadhesive polymer. Metoprolol release from the multiparticulate 
Mucoadhesive microspheres of Metronidazole                                                        Literature survey 
 
Adhiparasakthi college of pharmacy,Melmaruvathur. Page 44 
 
system was regulated and extended until 12 hours and exhibited a non fickian drug release 
kinetics approaching to zero order, as evident from the release rate exponent values which varied 
between 0.57 to 0.73. The stability studies performed on the optimized batches at 40°C / 75% 
RH for 90 days. 
 
Yadav N., et al. (2011) had to formulate and evaluated sustained release                                     
mucoadhesive microspheres of Acyclovir loader Sodiumcarboxymethylcellulose and              
hydrxypropylmethylcellulose were used as mucoadhesive polymers. The microspheres were 
prepared using solvent evaporation technique. The results of mucoadhesion study showed better 
retention of Sodium CMC microspheres (8.0±0.8 h) in duodenal and jejunum regions of 
intestine. Overall, the result indicated prolonged delivery with significant improvement in oral 
bioavailability of acyclovir from mucoadhesive microspheres due to enhanced retention in the 
upper GI tract. 
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                                             3. DRUG PROFILE 
 
 
                                     3.1METRONIDAZOLE                  (IP,2007) 
 
Metronidazole is a 5-nitroimidazole derivative with activity against protozoa like 
Balantidium coli, Blastocystis hominis, Entamoeba histolytica, Giardia intestinalis and 
Trichomonas vaginalis. 
The drug a l so  has  we l l -established ba c t e r i c id a l  ac t i v i t y ag a ins t  ob l iga t e  
ana erob ic  bacteria invitro, including Gram-negative organisms. 
Chemistry 
Metronidazole belongs to the class of nitroimidazoles. It‘s full chemical name is 2-(2- 
methyl-5-nitro-1H-imidazol-1-yl) ethanol or 1(2-hydroxyethyl) 2 methyl-5- nitroimidazole 
    
                                     
Pharmacology 
The mode of action involves reduction of Metronidazole by bacterial nitroreductases to an 
unstable intermediate, which interacts  with DNA, effectively preventing further 
replication. 
Pharmacokinetic s 
Absorption 
After oral administration, Metronidazole is well absorbed from the gastrointestinal tract, to 
the extent of about 100%.  Peak plasma concentrations of approximately 5 and 10mcg/ml 
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are achieved usually within 1 to 2 hours, after single doses of 250 and 500mg respectively. 
Distribution 
Metronidazole is widely distributed. It appears in most body tissues and fluids including  
saliva, bile, seminal fluid, breast milk, CSF bone, liver and liver abscesses, lungs and vaginal 
secretions, crosses the placenta and blood brain barrier. The volume of distribution is 0.55 L/kg 
in adults and 0.54- 0.81 L/kg in neonates. Protein binding of metronidazole is less than 20%. 
Metabolism 
Metronidazole is metabolized in the liver primarily by side chain oxidation and glucuronide 
conjugation. The principal oxidative metabolites are 1-(2-hydroxyethyl)-2- hydroxymethyl-5-
nitroimidazole, which has antibacterial activity and is detected in the plasma  and   urine,  and  
2-methyl-5-nitroimidazole  -1-  acetic  acid,  which  has  no antibacterial activity and is often not 
detected in plasma, but is excreted in urine. 
 
Elimination 
The mean elimination half – life of Metronidazole is about 6- 8 hours (range 6.0 to 
12.0h). the majority of a dose of Metronidazole is excreted in the urine, mainly as 
metabolites, a small amount appears in the faeces. 
 
Do sing   Info rmation 
Metronidazole is prescribed in: 
 
1. Amoebiasis:  Metronidazole  acts  as  an  amoebicide  at  all  sites  of  infection  with 
Entamaoeba  histolytica. Because of its rapid absorption it is probably less effective 
against parasites in the bowel lumen and is therefore used in conjunction with a luminal 
amoebicide such as diloxanide furoate. 
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Metronidazole is given in doses of 400 to 800mg three times daily by mouth for 5 to 10 
days. Children aged 1 to 3 years may be given one quarter, those aged 3 to 7 years one 
third and those aged 7 to 10 years one half the adult dose. An alternative adult dose is 
1.5to 2.5 g as a single dose daily for 2 to 3 days. 
2. Giardiasis:  The usual dose is 2g once daily by mouth for 3 successive days, or 400mg 
three times daily for 5 day, or 500mg twice daily for 7 to 10 days. 
3. Trichomoniasis: Metronidazole is given orally either as a single 2 g dose, as a 2-day 
course of 800mg in the morning and 1.2g in the evening, or as a 7-day course of 600mg 
to 1g daily in two or three divided doses. 
4. Bacterial vaginosis:  the usual dose is a single 2g dose or a 500mg twice daily for 5 to 
7 days.  
5. Anaerobic bacterial infection: Metronidazole is given by mouth in an initial dose of 
800mg followed by 400mg every 8 hours, usually for about 7 days. A regimen of 500mg 
every 8 hours is alternatively used. 
6. Peptic Ulcer disease:  Metronidazole is used in combination therapy to eradicate 
Helicobacter pylori.  The usual dose is 400mg twice daily.  When given along with 
omeprazole and amoxycillin, the dose is 400mg thrice daily. The treatment is continued 
for 1 week. 
Contraindications 
• Hypersensitivity to Metronidazole 
• Pregnancy 
• Breast-feeding Concominant anti-coagulant therapy 
• Blood dyscrasia, prior or current history 
• Severe hepatic function impairment 
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Adverse Effects 
 
The adverse effects of Metronidazole are generally dose related. The most common 
are gastrointestinal  disturbances,  especially  nausea  and  an  unpleasant  metallic  
taste. Vomiting and diarrhoea or constipation may also occur. Furred tongue, glossitis 
and stomatatis may be associated with an overgrowth of Candida. Weakness, dizziness, 
ataxia, headache, drowsiness, insomnia and changes in mood or mental state such as 
depression or confusion have also been reported. Peripheral neuropathy,   usually   
presenting   as   numbness   or   tingling   in   the   extremities   and epileptiform seizures 
are serious adverse effects on the nervous system that have been Associated with high doses 
of metronidazole on prolonged treatment. 
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3.2. POLYMERS  PROFILE:   
                                                                                       (Raymond C,Rowe.,et al., 2003)             
3.2.1. HYDROXY PROPYL METHYL CELLULOSE 
Synonyms:  Benecel, HPMC, Methocel, Hydroxy propyl methyl cellulose 
Molecular weight: 10,000-15,000 
Structure: 
 
Description : slightly off-white to beige powder in appearance and may be 
formed into granules. 
Colour : white to yellowish white 
Odour : odorless or nearly odorless 
Taste : bland taste 
Texture : powder 
Acidity / Alkalinity : pH 5.5-8.0 for a 1%w/w aqueous solution. 
Viscosity for 2 %( w/v) aqueous solution:   4000mpas (Viscosity measured at 200C) 
 Solubility: 
  Soluble in cold water, forming a viscous colloidal solution, practically 
insoluble in mixtures of ethanol and dichloromethane, mixtures of alcohol and water 
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Functional category:   
Coating agent, film former, and rate controlling polymer for sustained release, 
stabilizing agent, suspending agent and viscosity builder. 
Applications in pharmaceutical technology: 
High viscosity grades may be used to retard the release of drugs from a matrix 
at levels of 10-80%w/w in tablets and capsules. 
Stability and Storage:  
Stable between pH 3-11, should be stored in a well-closed container in a cool 
and dry place. 
Incompatibilities:  
Incompatible with some oxidizing agents such as hydrogen peroxide, 
potassium permanganate. 
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                                        3.2.2SODIUM ALGINATE        
                                                                          
                                                                          (Raymond C,Rowe.,et al., 2003)                       
 
Nonproprietary Names: 
BP: Sodium Alginate 
PhEur: Sodium Alginate 
USP-NF: Sodium Alginate 
Synonyms: 
Alginato sodico; algin; alginic acid, sodium salt; E401; Kelcosol; Keltone; natrii 
alginas; Protanal; sodium polymannuronate. 
Chemical Name: Sodium alginate  
CAS Registry Number: [9005-38-3] 
Empirical Formula and Molecular Weight: 
Sodium alginate consists chiefly of the sodium salt of alginicacid, which is a mixture 
of polyuronic acids composed of residues of Dmannuronicacid and L-guluronic acid. 
Structural Formula: 
 
             
 
 
Functional Category 
Stabilizing agent; suspending agent; tablet and capsule disintegrant; 
Description 
Sodium alginate occurs as an odorless and tasteless, white to pale yellowish-brown 
colored powder 
Mucoadhesive microspheres of Metronidazole Drug and polymer profile 
 
Adhiparasakthi college of pharmacy, Melmaruvathur. Page 53 
 
Colour            : pale yellowish-brown 
Odour             : odorless. 
Taste             : tasteless 
Texture          :  powder  
Acidity/alkalinity: pH _ 7.2 (1% w/v aqueous solution) 
Solubility: 
Practically insoluble in ethanol (95%), ether, chloroform, and ethanol/water mixtures 
in which the ethanol content is greater than 30%. Also, practically insoluble in other 
organic solvents and aqueous acidic solutions in which the pH is less than 3. Slowly 
soluble in water, forming a viscous colloidal solution. 
Stability and Storage Conditions: 
Sodium alginate is a hygroscopic material, although it is stable if stored at low 
relative humidities and a cool temperature. Aqueous solutions of sodium alginate are 
most stable at pH4–10. Below pH 3, alginic acid is precipitated. A 1% w/v aqueous 
solution of sodium alginate exposed to differing temperatures had a viscosity 60–80% 
of its original value after storage for 2 years. Solutions should not be stored in metal 
containers. Sodium alginate solutions are susceptible on storage to microbial spoilage, 
which may affect solution viscosity. Solutions are ideally sterilized using ethylene 
oxide, although filtration using a 0.45 mm filter also has only a slight adverse effect 
on solution viscosity. Heating sodium alginate solutions to temperatures above 70°C 
causes depolymerization with a subsequent loss of viscosity. Autoclaving of solutions 
can cause a decrease in viscosity, which may vary depending upon the nature of any 
other substances present. Gamma irradiation should not be used to sterilize sodium 
alginate solutions since this process severely reduces solution viscosity. Preparations 
for external use may be preserved by the addition of 0.1% chlorocresol, 0.1% 
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chloroxylenol, or parabens. If the medium is acidic, benzoic acid may also be used. 
The bulk material should be stored in an airtight container in a cool, dry place. 
Incompatibilities: 
Sodium alginate is incompatible with acridine derivatives, crystal violet, phenyl 
mercuric acetate and nitrate, calcium salts, heavy metals, and ethanol in 
concentrations greater than 5%. Low concentrations of electrolytes cause an increase 
in viscosity but high electrolyte concentrations cause salting-out of sodium alginate; 
salting-out occurs if more than 4% of sodium chloride is present. 
Applications in Pharmaceutical Formulation or Technology: 
1. Sodium alginate is used in a variety of oral and topical pharmaceutical 
formulations. 
2.  In tablet formulations, sodium alginate may be used as both a binder and 
disintegrant ; it has been used as a diluent in capsule formulations. 
3. Sodium alginate has also been used in the preparation of sustained-release oral 
formulations since it can delay the dissolution of a drug from tablets, capsules 
and aqueous suspensions. 
4.  The effects of particle size, viscosity and chemical composition of sodium 
alginate on drug release from matrix tablets have been described.  
5. In topical formulations, sodium alginate is widely used as a thickening and 
suspending agent in a variety of pastes, creams, and gels, and as a stabilizing 
agent for oil-in-water emulsions.  
6. Recently, sodium alginate has been used for the aqueous microencapsulation 
of drugs, in contrast with the more conventional microencapsulation 
techniques which use organic solvent systems. It has also been used in the 
formation of nanoparticles 
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      Table1 3.1.Sodium alginate is also used in cosmetics and food products  
USE CONCENTRATION (%) 
Pastes and creams 5-10 
Stabilizer in emulsions 1-3 
Suspending agent 1-5 
Tablet binder 1-3 
Tablet disintegration 2.5-10 
 
                       3.2.3 Methylcellulose                
                                       
                                         (Raymond C,Rowe.,et al., 2003)             
 
Nonproprietary Names: 
BP: Methylcellulose 
JP: Methylcellulose 
PhEur: Methylcellulose 
USP: Methylcellulose 
Synonyms: 
Benecel; Cellacol; Culminal MC; E461; Mapolose; Methocel; methylcellulosum; 
Metolose; Tylose; Viscol. 
Chemical Name and CAS Registry Number: 
Cellulose methyl ether [9004-67-5] 
Empirical Formula and Molecular Weight: 
Methylcellulose is long-chain substituted cellulose in which approximately 27–32% 
of the hydroxyl groups are in the form of the methyl ether. The various grades of 
methylcellulose have degrees of polymerization in the range 50–1000, with molecular 
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weights (number average) in the range 10 000–220 000 Da. The degree of substitution 
of methylcellulose is defined as the average number of methoxyl (CH3O) groups 
attached to each of the anhydroglucose units along the chain. The degree of 
substitution also affects the physical properties of methylcellulose, such as its 
solubility. 
Structural Formula: 
                          
Description 
Methylcellulose occurs as a white, fibrous powder or granules. It is practically 
odorless and tasteless. It should be labeled to indicate its viscosity type (viscosity of a 
1 in 50 solution). 
Functional Category 
Coating agent, emulsifying agent, suspending agent, tablet and capsule disintegrant, 
tablet binder, viscosity-increasing agent. 
 Applications in Pharmaceutical Formulation or Technology 
1. Methylcellulose is widely used in oral and topical pharmaceutical 
formulations 
2. In tablet formulations, low- or medium-viscosity grades of methylcellulose are 
used as binding agents, the methylcellulose being added either as a dry powder 
or in solution. Highviscosity grades of methylcellulose may also be 
incorporated in tablet formulations as a disintegrant. 
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3. Methylcellulose may be added to a tablet formulation to produce sustained-
release preparations. 
4. Tablet cores may also be spray-coated with either aqueous or organic solutions 
of highly substituted low-viscosity grades of methylcellulose to mask an 
unpleasant taste or to modify the release of a drug by controlling the physical 
nature of the granules. 
5. Methylcellulose coats are also used for sealing tablet cores prior to sugar 
coating. 
6. Low-viscosity grades of methylcellulose are used to emulsify olive, peanut, 
and mineral oils. 
7. They are also used as suspending or thickening agents for orally administered 
liquids, methylcellulose commonly being used in place of sugar-based syrups 
or other suspension bases. 
8. Methylcellulose delays the settling of suspensions and increases the contact 
time of drugs, such as antacids, in the stomach. 
9.  High-viscosity grades of methylcellulose are used to thicken topically applied 
products such as creams and gels. 
10.  In ophthalmic preparations, a 0.5–1.0% w/v solution of a highly substituted, 
high-viscosity grade of methylcellulose has been used as a vehicle for eye 
drops. However, hypromellose-based formulations are now preferred for 
ophthalmic preparations.  
11. Methylcellulose is also used in injectable formulations. Therapeutically, 
methylcellulose is used as a bulk laxative; it has also been used to aid appetite 
control in the management of obesity,but there is little evidence supporting its 
efficacy. 
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                     3.2.4   Calcium Chloride  
                                                                                     (Raymond C,Rowe.,et al., 2003)                 
 
Nonproprietary Names 
 
BP: Calcium Chloride Dihydrate, Calcium Chloride Hexahydrate 
 JP: Calcium Chloride Hydrate 
   hEur: Calcium Chloride Dihydrate 
 Synonyms 
Calcium chloridum dihydricum; calcium chloridum hexahydricum. 
Chemical Name and CAS Registry Number 
Calcium chloride anhydrous [10043-52-4] 
Calcium chloride dihydrate [10035-04-8] 
Calcium chloride hexahydrate [7774-34-7] 
Empirical Formula and Molecular Weight 
CaCl2 110.98 (for anhydrous) 
CaCl2_2H2O 147.0 (for dihydrate) 
CaCl2_6H2O 219.1 (for hexahydrate) 
Structural Formula 
 
Functional Category 
Antimicrobial preservative; therapeutic agent; water-absorbinggent. 
Description 
Calcium chloride occurs as a white or colorless crystalline powder, granules, 
crystalline mass, and is hygroscopic (deliquescent). 
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Applications in Pharmaceutical Formulation or Technology 
The main applications of calcium chloride as an excipient relate to its dehydrating 
properties and therefore it has been used as an antimicrobial preservative, as a 
desiccant, and as an astringent in eye lotions. 
Therapeutically, calcium chloride injection 10% (as the dehydrate form) is used to 
treat hypocalcaemia. 
Stability and Storage Conditions 
Calcium chloride is chemically stable; however, it should be protected from moisture. 
Store in airtight containers in a cool, dry place. 
Incompatibilities 
• Calcium chloride is incompatible with soluble carbonates, phosphates, 
sulfates, and tartrates.  
• It reacts violently with bromine trifluoride, and a reaction with zinc releases 
explosive hydrogen gas. 
• It has an exothermic reaction with water, and when heated to decomposition it 
emits toxic fumes of chlorine. 
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4. AIM AND OBJECTIVES 
Amoebiasis  is  an  infection  caused  by  Entamoeba  histolytica,  a  single  
celled protozoan  parasite. The current estimate is that E. histolytica causes 
between 34-50 million symptomatic infections leading to the death of 40-100 
thousands of people, which makes Amoebiasis second only to malaria as a cause 
of death resulting from protozoan parasite. The most preferred choice of drugs for  
Amoebiasis is metronidazole.    
. The present study was aimed to develop and evaluate mucoadhesive 
microspheres of Metronidazole for better treatment of Amoebiasis and other 
protozoal infections.  metronidazole could prevent unwanted systemic side effects 
and subsequently a lower dose of the drug may be sufficient to treat protozoal 
infections. 
 
Objectives: 
The development of efficient orally delivered mucoadhesive drug   delivery system  
includes advantages like: 
 
 Maximized absorption rate is mainly due to intimate contact of drug with  the 
mucus membrane to improve and enhance bioavailability of drugs. 
    Drug protection is improved by polymer encapsulation and longer gut transit time 
is obtained, resulting in extended periods for absorption. 
    Multiple dosing is avoided and there by counteracts the side effects. 
  The main objective is mainly to develop  mucoadhesive microspheres of 
Metronidazole by orifice-ionic gelation process using mucoadhesive polymers 
release of the drug for extended period of time. 
    Formulate and evaluate the microspheres of  Metronidazole. 
    To  study  the  effect  of  different  polymers  and  different  ratios  of  
polymers
 employed. 
    Performing the stability studies as per ICH guidelines. 
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5. PLAN OF WORK 
 
 Literature survey.  
 Materials and equipments. 
   Pre formulation studies. 
 Characterization of Drug. 
 Appearance. 
 Melting Point Determination. 
 Solubility Study. 
 UV Spectroscopy (λmax). 
 IR Spectroscopy. 
 Loss on drying. 
 Drug - Polymers Interaction Studies. 
 Fourier transforms Infra-Red (FTIR) Spectroscopy Study. 
 Differential Scanning Calorimetry (DSC) Analysis. 
 Preparation of Metronidazole mucoadhesive microspheres. 
 Evaluation of Metronidazole mucoadhesive microspheres. 
      # Percentage yield 
 
 # Particle Size analysis 
 
      # Drug content estimation and Encapsulation efficiency 
 
               # Percentage moisture content 
 
      # Scanning electron microscopy 
 
      # In -vitro wash - off test for Mucoadhesion 
 
      # In -vitro drug release studies. 
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 Results and Discussion. 
 Summary and Conclusion. 
 Future Prospects. 
 Bibliography. 
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6. MATERIALS AND EQUIPMENTS 
 
6.1. List of  Materials used with Sources 
Table 6.1: List of Materials and their Suppliers 
S.No. Name of Material Supplied by 
1 Metronidazole 
Bindu pharmaceuticals, 
Hyderabad. 
2 Sodium alginate 
Bindu pharmaceuticals, 
Hyderabad. 
3 Hydroxy propyl methyl cellulose Loba chemie pvt ltd,Mumbai 
4 Methyle  cellulose Loba  chemie pvt ltd,Mumbai 
5 Calcium chloride 
Qualigens fine chemicals, 
Mumbai 
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6.2.  List of Equipments used with model: 
         Table 6.2 : List of equipments with their make  
S.No. Name of the equipment Make 
1  Electronic balance Shimadzu, Japan 
2 UV-Visible spectrophotometer Shimadzu, Japan 
3 Standared coating pan Ganson-india 
4 FTIR Spectrophotometer Shimadzu 
5 DSC test apparatus  Mettler Teldo 
6 Dissolution test apparatus  Vigo Scientifics,  Mumbai 
7 Digital pH meter  Elico Scientifics,  Mumbai 
8 Hot air oven Precision scientific co., Chennai 
9 Humidity chamber Lab tech, Ambala 
10 Tap density apparatus Indo labs, Chennai 
11 Melting point test apparatus Precision scientific co., Chennai 
12 Optical microscope Mettler Toledo 
13 SEM Merlin-FE-SEM 
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                                      7. EXPERIMENTAL WORK 
 
7.1. PREFORMULATION STUDY 
 
Before formulating a product, the physical and chemical properties of a drug 
substance have undergone some pre-formulation testing. It is the first step in rational 
development of dosage form. 
7.1.1. Identification of drug 
 
7.1.1. a) Identification by FTIR spectroscopy          (Skoog D.A., et al., 1996; IP,2007) 
 
Metronidazole discs were prepared by pressing the Metronidazole with 
potassium bromide and the spectra in between 4000 to 500 cm-1 was obtained under 
the operational conditions.  The absorption maximums in spectrum obtained with the 
substance being examined correspond in position and relative intensity to those in the 
reference spectrum represented in Table 8.1 and shown in Figure 8.1. 
7.1.1. b) Identificationby melting point                                    (Moffat A C. et al.,2004) 
 
Melting point of the drug was determined by capillary tube method. 
 
7.1.2. Physicochemical parameters 
 
7.1.2. a) Organoleptic properties                                             (Lachman L.,et al.,1991) 
 
The color, odor and taste of the drug were recorded using descriptive 
terminology. 
 
7.1.2. b) Solubility study                                                           (Moffat A C ., et al.,2004) 
 
It is important to know about solubility characteristic of a drug in aqueous 
system, since they must possess some limited aqueous solubility to elicit a therapeutic 
response. The solubility of drug was recorded by using various descriptive 
terminologies. The solubility profile was represented in Table 8.2. 
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7.1.3. Analytical methods 
 
7.1.3. a) Determination of λ max                          (Swamy P.V., et al., 2007; USP,2009) 
 
The absorption maximum of the standard solution was scanned between 200-
400 nm regions on UV-Visible spectrophotometer. The absorption maximum 
obtained with the substance being examined corresponds in position and relative 
intensity to those in the reference spectrum was shown in Figure 8.2. 
7.1.3. b) Development of standard curve of Metronidazole                                 
 
                                                                  (IP,1997;USP,2009) 
1} Pre p arati o n  of    (pH  1.2  ).    
 
8.5ml  concentrated  Hydrochloric  acid  and  0.8gm  of  Sodium  chloride  
were dissolved in 1000ml of distilled water. 
     Principle 
 
Metronidazole showed maximum absorbance at 276 nm in pH 1.2  and obeyed 
Beer’s law at the concentration range between 5-30 mcg/ml. 
       Procedure 
 
Stock solution 
 
Weighed quantity of Metronidazole (50mg) was dissolved in pH 1.2  and the 
volume was made up to 50ml with the same medium. 
1000 mcg/ml (Standard stock solution - I)  
 
1ml of SS I was then made up to 10ml with the same medium. 
 
100 mcg/ml  (Standard stock solution- II) 
Aliquots of 0.5,1,1.5,2,2.5,3 ml of SSS II was pipetted into 10ml volumetric   
flasks  and  the  volume  was  made  upto  10ml  with  pH1.2.  The absorbance was 
measured at 276 nm against reagent blank (pH 1.2). 
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2} Pre p arati o n of Phos phate Buff er ( p H 7.4) . 
 
 
                 50ml of 0.2M potassium dihydrogen phosphate and 39.1 ml of 0.2 M NaOH 
were   taken in a 200ml volumetric flask and the volume was made up with water. 
 
 
 
Instrument 
 
Elico UV-Visible Spectrophotometer SL 159. 
 
 
 
 
Principle 
 
Metronidazole showed  maximum  absorbance  at  319  nm  in  Phosphate  
buffer pH 7.4 and obeyed Beer’s law at the concentration range between 5-30 mcg/ml. 
 
 
Procedure 
 
Stock solution 
 
Weighed quantity of Metronidazole (50mg) was dissolved in Phosphate 
buffer pH 7.4 and the volume made up to 50ml with Phosphate buffer pH 7.4. 
1000 mcg/ml (Standard stock solution- I). 
 
1ml of SS I was then made up to 10ml with the same medium 
 
 100 mcg/ml (Standard stock solution- II). 
 
Aliquots of 0.5, 1, 1 . 5 , 2, 2.5, 3 ml of SSS II was pipetted into 10ml 
volumetric flasks and the volume was made up to 10ml with Phosphate buffer pH 
7.4. The absorbance was measured at 319 nm against reagent blank (Phosphate 
buffer pH7.4). 
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7.1.3. c) Determination of Percentage purity of Drug                              (IP, 2007) 
Accurately weighed 100 mg of Metronidazole was dissolved in little quantity of 
methanol to get the concentration of 1mg/ml. The solution was pipetted out of about 0.5 
ml to 3 ml and volume was made up with distilled water. From the above stock solution, 
the concentration and absorbance was observed. The absorbance was measured at 276 
nm against the blank using by UV-Visible spectrophotometer. The percentage purity of 
drug was calculated by using calibration curve method(least square method). The data of 
percentage purity was represented in Table 8.5. 
 
7.1.4. DRUG EXCIPIENT INTERACTION STUDIES 
 
7.1.4. a) Determination of drug-polymer compatibility          (Aulton M.E.,et al.,2002) 
The proper design and formulation of a dosage form requires consideration of 
the physical, chemical and biological characteristics of all drug substances and 
excipients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1: Schematic representation of compatibility studies 
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7.1.4. b) Fourier transform Infra-Red (FTIR) spectroscopy                        (IP, 2007) 
 
FTIR study was carried out to check compatibility of drug with polymers. 
Fourier transform Infrared Spectrophotometer was determined by using KBr 
dispersion method. The base line correction was done using dried potassium bromide. 
Then the spectrum of dried mixture of Metronidazole and potassium bromide was run 
followed by Metronidazole with various polymers by using FTIR spectrophotometer. 
The absorption maximums in spectrum obtained with the substance being examined 
correspond in position and relative intensity to those in the reference spectrum was 
represented in Table 8.6 and shown in Figure 8.4, 8.5, 8.6 and 8.7. 
7.1.4. c) Differential scanning calorimetry (DSC)                   (AultonM.E., et al.,2002) 
 
Any possible drug polymer interaction can be studied by thermal analysis. The 
DSC study was performed on pure Metronidazole, Metronidazole with HPMC, 
Metronidazole with Methyl cellulose and Metronidazole with sodium alginate. The 2 
mg of sample were heated in a hermetically sealed aluminum pans in the temperature 
range of 25-300ºC at heating rate of 10ºC /min under nitrogen flow of 30ml/min. The 
results of DSC analysis were represented in Table 8.7and showed in Figure 8.8, 8.9, 
8.10 and 8.11. 
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7.2 METHOD OF PREPARATION OF METRONIDAZOLE    
        MICROSPHERES                                 (Sambathkumar.r., et al.,2011) 
7.2 Table    7.1: Formulation of metronidazole microspheres 
 
 
S.No. 
 
Batch.No. 
 
Drug (g) 
 
Sodium 
alginate (%) 
 
HPMC 
(%) 
 
Methyle 
cellulose 
 
 
1 
 
 
F1 
 
 
1 
 
 
1.5 
 
 
- 
 
 
- 
 
2 
 
F2 
 
1 
 
2.5 
 
- 
 
- 
 
;3 
 
F3 
 
1 
 
3.5 
 
- 
 
- 
 
4 
 
        F4 
 
1 
 
1.5 
 
2 
 
- 
 
5 
 
F5 
 
1 
 
2.5 
 
2 
 
- 
 
6 
 
F6 
 
1 
 
3.5 
 
2 
 
- 
 
7 
 
F7 
 
1 
 
1.5 
 
- 
 
1 
 
8 
 
 
         F8 
 
1 
 
2.5 
 
- 
 
1 
 
9 F9 1 3.5 - 1 
 
 
7.2.1. Orifice ionic gelation method (syringes method)       (Swamy P.V., et al., 2007) 
 
 
In this technique cross linking was done with calcium chloride solution to 
release the drug in a controlled manner. Microspheres were prepared by using the 
Orife ionic gelation technique in which Sodium alginate, HPMC, Methylcellulose in 
different ratios as mentioned above  was  added to 32ml of water with continuous 
stirring to form homogenous solution Then sonicating was done for 20 minutes the 
drug Metronidazole was then added to the above solution to form a clear solution. The 
drug polymer mixture was poured in1.5% calcium chloride solution using 22# gauge 
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needle by stirring at 50rpm. The microspheres thus formed were allowed for 30 min 
Then the calcium chloride solution was decained and The formed mucoadhesive 
microspheres  washed with distilled water and air dried over night at room 
temperature 
 
The flow chart of preparation of Metronidazole microspheres 
                                     
Polymers + Metronidazole
 
 
                                                                              Added 
 
                                                                Calcium chloride 
 
 
                                                                              To form 
                                                                
                                                                   Microspheres 
 
                   
 
 
Figure.7.2: Preparation of microspheres using 22# syringe needle in magnetic 
stirrer 
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7.3. EVALUATION AND CHARACTERIZATION OF MICROSPHERES 
 
 
(Bhabani Nayak S., et al., 2009) 
 
Appropriate assessment of a dispersed system requires characterization of 
both chemical and physical stabilities. Physical properties are very important with 
respect to the performance of dispersed systems. 
 
7.3.1Particle Size Determination 
( Swamy P.V., et al.,2007) 
               Particle size distribution for the microspheres were measured by sieving 
method analysis, using set of standard sieves was weighed.  Particles having size range 
between 50 and 1500 μm are estimated by sieving method. This method directly gives 
weight distribution. The sieving method is a useful application in dosage form 
development of tablets and spheres 
 
7.3.2. Percentage Yield                                                 (BhabaniNayak S., et al., 2009) 
 
 
The  total  amount  of  microspheres  obtained  were  weighed  and  evaluated  
for percentage yield. 
Percentage yield= 
Practical yield  
X 100 
 Theoretical yield 
 
                           
7.3.3. Drug content estimation and Entrapment efficiency 
(Swamy P.V., et al., 2007) 
            Metronidazole microspheres (100mg) from each batch were initially stirred in 3 ml 
sodium citrate solution (1%w/v) until complete dissolution.  A quantity of 7 ml of methanol 
was added to above solution to solubilise  the Metronidazole. The filtrate was assayed for 
drug content by measuring the absorbance at 276 nm after suitable dilution by UV-Visible 
spectrophotometer and Encapsulation efficiency was calculated using the formula, 
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Encapsulation efficiency = 
Estimated % drug content in microspheres 
× 100 Theoretical % drug content in microspheres 
 
 
7.3.4. Percentage  moisture content:                                (Bhabani Nayak S., et al., 2009) 
                          The Metronidazole loaded microspheres was evaluated to determine the 
percentage moisture content which sharing an idea about its hydrophilic nature. The 
microspheres weighed (w1) initially kept in desiccator containing Calcium chloride at 
37º C for 24 hours. The final weight (w2) was noted when no further change in weight of 
sample was observed. 
 Moisture Percentage = W1 – W  2 × 100 W2 
 
7.3.5. Scanning electron microscopy (SEM):                            (Swamy P.V,.et al.,2007) 
                                  The microspheres were observed under a Scanning Electron Microscopy. 
They were  mounted  directly  onto  SEM  sample  stub  using  double-sided  sticking  tape  
and coated with gold film with ion spillter with gold target with resolution 3 nm (30 KV 
HV Mode),10 nm (30 KV HV Mode), 40 nm (30 LV Mode) and a vacuum system is  
fitted to it. 
 
7.3.6. In -vitro wash off test for mucoadhesion: 
                           (BhabaniNayak S., et al., 2009) 
      
The  mucoadhesive  property o f  t h e  metronidazole microspheres w a s  evaluated  
by an in -vitro adhesion testing method known as the wash – off method. Freshly 
excised pieces of intestinal mucosa (4×5 cm) from sheep were mounted onto glass 
slides (3×1inch) with poly cyanoacrylate glue. Two glass slides were connected with a 
suitable each wet rinsed tissue specimen, and immediately thereafter the support were  
hung  onto  the  arm  of  a  USP  tablet  disintegrating  test  machine.  When  the 
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disintegrating test machine was operated, the tissue specimen was given a slow, regular up 
and down movement in the test fluid (400ml) at 37ºC contained in a 1000 ml vessel of the 
machine. At the end of 1 hr and at hourly interval up to 8 hr, the machine was stopped and 
the number of microsphere still adhering to the tissue was counted. The test was 
performed in stomach (pH1.2). 
7.3.7 .In- vitro drug release studies 
(USP, 2009; Swamy P.V.,et al., 2007;Chowdary K. P. R., et al., 2004) 
In-vitro drug release study was carried out in USP dissolution test apparatus. A quantity 
of microspheres equivalent to 100 mg of Metronidazole microspheres was kept in basket 
type apparatus and immersed in 900ml of  phospate buffer (pH 1.2) in 1000 ml 
dissolution flask and temperature was maintained at 37 ± 0.5ºC throughout the study. At 
predetermined time intervals 2 ml of samples was withdrawn by means of a syringe fitted 
with prefilter and same was replaced into the dissolution flask containing pH 1.2.  
The absorbance of sample was measured at 276 nm after required dilution with the fresh 
medium (pH.1.2).All the studies were conducted in triplicate. 
7.3.8. Kinetics of In-vitro drug release 
                                               (Swamy P.V., et al. 2007; Bhabani Nayak S.,et al.,2009)  
In-vitro drug released data was subjected to in- vitro kinetic models such as zero order  
 first order, Higuchi and Korsemeyer- Peppas 
 
Zero order:        C = K0t 
Where    K0 - is the zero-order rate constant expressed in units of concentration/time                                                
t -is the time in hrs 
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        First order:         Log C = LogC0 – Kt / 2.303 
Where   C0 - is the initial concentration of drug, 
              K - is the first order constant 
               t - is the time in hrs. 
     Higuchi:                           Qt = Kt1/2 
Where   Qt - is the amount of the release drug in time t, 
            K- is the kinetic constant and t- is time in hrs 
 
KorsmeyerPeppas:                    Mt/ M∞ = Kt 
Where Mt - represents amount of the released drug at time t, 
                  M∞- is the overall amount of the drug (whole dose) released after 12 hrs 
                   K- is the diffusional characteristic of drug/ polymer system constant 
                   n- is a diffusional exponent that characterizes the mechanism of release of drug. 
Table 7.2: Diffusion exponent and solute release mechanism 
 
Diffusion exponent (n) 
 
Overall solute diffusion mechanism 
< 0.5 Quasi-Fickian diffusion 
0.5 Fickian diffusion 
0.5 < n < 1.0 Anomalous (non-Fickian) diffusion 
1.0 Case-II transport 
> 1.0 Super case-II transport 
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 7.4. STABILITY STUDY 
                                                             (Manavalan R. and Ramasamy S., 2004) 
In any rational drug design or evaluation of dosage forms, the stability of 
the active component was a major criterion in determining their acceptance or 
rejection. 
     Objective of the study 
The purpose of stability testing was to provide the evidence on how the 
quality of a drug substance or drug product varies with time under the influence of a 
variety of environmental factors such as temperature, humidity and light, enabling 
recommended storage conditions, re-test periods and shelf-lives. The International 
Conference on Harmonization (ICH) Guidelines titled “Stability testing of New Drug 
Substances and Products describes the stability test requirements for drug registration 
application in the European Union, Japan and the States of America. 
ICH specifies the length of study and storage conditions 
 
       Long-Term Testing: Room temperature; 25˚ C ±2 C at 60% RH ±5%   for 12 months 
 
      Accelerated Testing: Accelerated temperature; 40˚ C ±2 C at 75% RH ±5% for 6             
months 
 
In present study the optimized formulation F9 was exposure up to 3 months              
Stability studies at accelerated condition (40˚ C ±2 C at 75% RH ±5%RH) to find out the 
effect of aging on drug content and In-vitro drug release. 
    Procedure 
The formulation (F9) was stored at accelerated condition in aluminum foils for 3 
months. The samples were withdrawn after end of 1st month, 2nd month and 3rd month. 
The samples were analyzed for its drug content and in vitro drug release. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results and  
discussion
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8. RESULTS AND DISCUSSION
                   
 
 
          8.1. PREFORMULATION PARAMETERS 
 
    8.1.1. Identification of drug 
 
    8.1.1. a) Identification by FTIR spectroscopy 
 
The FTIR spectrum   of Metronidazole   was shown in Figure 8.1 and the 
interpretations of IR frequencies were represented in Table 8.1. 
Figure 8.1: FTIR spectrum of metronidazole 
 
Interpretation of FTIR Spectrum 
 
Major functional groups present in metronidazole showed characteristic 
peaks in FTIR spectrum.  The  major  peaks  were  identical  to  functional  
group  of metronidazole Hence, the sample was confirmed as metronidazole. 
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Table8.1:Characteristic frequencies in FTIR spectrum of                                            
metronidazole 
 
 
Inference Wave no.(cm-1) 
O-H stretching 3648 
N-H stretching 3221-3101 
C-H stretching 2982-2937 
C-O stretching 1354-1265 
C-H bending(In plane) 1428-1368 
C-C stretching 1187-907 
 
 
8.1.1. b) Melting point 
 
Melting point values of metronidazole sample was found to be in range 
of 160±1.660C, the reported melting point for metronidazole was. 159-163°C 
Hence, experimental values were same as official values. 
8.1.2. Physicochemical parameters of drug 
8.1.2. A) Organoleptic properties 
           Odour: Characteristic 
           Colour: Yellow colour 
           Nature: Crystalline powder 
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8.1.2. B) Solubility study 
 
        Table 8.2: Solubility of metronidazole in various solvents 
 
 
 
 
Name of solvent 
Standard Parts of 
solvent required for 
part of solute 
 
 
 
Solubility 
Distilled water From 30 to 100 Slightly Soluble 
Acetone From 30 to 100 Slightly Soluble 
Methanol From 1 to 30 Highly soluble 
Alcohol From 1 to 30 Highly Soluble 
Isopropyl alcohol More than 1000 Freely soluble 
Acetone More than 10000 Partially insoluble 
 
 
 
8.1.3. Loss on drying  
The percentage loss on drying after 3 hours was represented in Table 8.3. 
 
 
Table 8.3: Percentage loss on drying for Metronidazole 
 
The sample passes test for loss on drying as per the limit specified (N.M.T.1%)     
 
 
 
 
S. No. Percentage  LOD Average percentage LOD 
1 0.3 
 
0.533 
 
2 0.6 
3 0.7 
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8.1.3. Analytical methods 
 
8.1.3. a) Determination of λ max 
 
The absorption maximum for metronidazole was found at 276nm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    Figure 8.2: λ max observed for metronidazole in pH 1.2  
 
8.1.3. B) Preparation of standard graph of metronidazole 
 
     UV absorption spectrum of metronidazole in pH showed   λ max at 276nm in figure 8.2. 
Absorbance obtained for various concentrations of metronidazole in pH 1.2 were 
represented in T a b l e  8 . 4 .The g r a p h  o f  absorbance vs. concentration for 
metronidazole was found to be linear in the concentration of 5-30 μg/ml. The drug obeys 
Beer-Lambert’s law in the range of 5-30 μg/ml. was shown in figure 8.3 
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Table 8.4: Data of concentration vs absorbance for metronidazole in pH 1.2  
 
 
 
S.No. 
 
Concentration 
 
(µg/ml) 
 
 
Absorbance 
(nm) 
1 0 0.000 
2 5 0.087 
3 10 0.194 
4 15 0.292 
5 20 0.390 
6 25 0.486 
7 30 0.579 
 
 
 
                        
          
 
 
    Figure 8.3: Standard curve for metronidazole in pH 1.2 
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                                     Table 8.5: Data for calibration curve parameters 
 
 
S. No. 
 
Parameters 
 
Values 
 
1 
 
Correlation coefficient (r) 
 
0.9998 
 
2 
 
Slope 
 
0.05124 
 
3 
 
Intercept 
 
0.154 
 
8.1.3C) Determination of λmax and Preparation of Calibration Curve of Metronidazole 
by using  pH 7.4: 
UV absorption spectrum of Metronidazole in pH 7.4 showed λmax at 319 nm. in 
figure 8.4. Absorbance obtained for various concentrations of Metronidazole was found to be 
linear in the concentration range of 5 – 30 μg /ml. The Metronidazole absorbance in 
Phosphate buffer pH 7.4 was given in Table 8.6. The graph of absorbance concentration for 
drug obeys Beer- Lambert’s law in the range of 5 – 30 μg /ml. was shown in figure 8.5 
 
Fig. 8.4: Absorption maximum of Metronidazole in Phosphate buffer pH 7.4       
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            Table 8.6: Data of concentration vs absorbance for metronidazole in pH 7.4 
 
 
 
S.No. 
 
Concentration 
 
(µg/ml) 
 
 
Absorbance 
nm 
1 0 0.000 
2 5 0.12 
3 10 0.24 
4 15 0.409 
5 20 0.561 
6 25 0.708 
7 30 0.849 
 
 
        
           
                              Figure.8.5: Standard curve for metronidazole in pH 7.4 
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                                     Table 8.7: Data for calibration curve parameters 
 
 
S. No. 
 
Parameters 
 
Values 
 
1 
 
Correlation coefficient (r) 
 
0.9989 
 
2 
 
Slope 
 
0.034 
 
3 
 
Intercept 
 
0.754 
 
 
8.1.3. D) Percentage purity of drug 
 
The  percentage  purity  of  drug  was  calculated  by  using  calibration  
graph method (least square method).The average percentage purity was 
represented in Table 8.8. 
 
                                     Table 8.8: Data of percentage purity of drug 
 
 
 
S. No. 
 
Percentage purity 
(%) 
 
Avg. percentage purity 
(%) 
 
1 
 
99.87 
 
 
 
 
 
     100.11±0.240 
 
2 
 
100.12 
 
3 
 
100.35 
                             All values are expressed as mean± S.D., n=3 
 
             The  percentage purity for Metronidazole in IP 2007 is not less than 99.0 % and not  
 
More than 101.0 % of the stated amount of Metronidazole. The Average percentage purity 
was represented in Table 8.8. 
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8.1.4.A) Determination of compatibility for drug with polymer 
FTIR spectroscopy.  
 
Fig. 8.6: FT-IR spectra of Metronidazole with Sodium alginate 
 
 
 
 
Fig. 8.7: FT-IR spectra of Metronidazole with HPMC 
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Fig. 8.8:FT-IR spectra of Metronidazole with Methylcellulose: 
 
 
Table 8.9: The major peak observed in FTIR spectrum of metronidazole 
and Metronidazole with different polymers. 
 
Wave No. 
(cm-1) 
 
Functional 
group 
Peak observed (Yes/No) 
 
Metronidazole 
Metronidazole 
with 
Sodiumalginate 
Metronidazole 
with HPMC 
Metronidazole 
with Methyle 
cellulose 
 
3648 
O-H 
Stretching 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
3221-3101 
N-H 
Stretching 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
2982-2937 
C-H 
Stretching
g 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
 
1354-1265 
C-O 
stretching 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
1428-1368 
C-H 
bending(in 
plane) 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
1340 
 
C-C 
stretching 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
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                The   major   peaks   of  Metronidazole  spectrum   were   compared   to 
Metronidazole with polymers spectrum. There was no interaction between Metronidazole 
and polymers. The data was represented in Table 8.9 and shown in Figure 8.6, 8.7,  and 
8.8. 
 
8.1.4. B) DSC thermal analysis:  
              The interactions between Metronidazole and polymers were determined by 
DSC studies and results were represented in Table 8.7 and shown Figure 8.9, 8.10, 8.11 
and 8.12. 
 
 
 
 
 
 
 
 
 
Figure 8.9: DSC thermogram for Metronidazole 
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Figure 8.10: DSC thermogram for Metronidazole with Sodium alginate 
 
 
 
 
Figure 8.11: DSC thermogram for Metronidazole with HPMC 
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Figure.8.12: DSC thermogram for Metronidazole with methyle  cellulose 
 
 
 
 
 
                                   Table 8.10: Various DSC Thermogram parameter 
 
 
 
S.NO 
 
DSC Graphs
 
 
Peak 
( ºC )
 
 
Onset 
temperature    
( ºC )
 
 
Endset 
temperature 
( ºC )
 
1 
 
Metronidazole  160.88 
 
160.01 
 
164.65 
2 
Metronidazole+ 
Sodium 
alginate 
 
161.20 
 
160.98 
 
163.48 
3 Metronidazole+ HPMC 
 
160.18 
 
160.78 
 
163.64 
4 
Metronidazole+ 
Methyl 
cellulose 
 
160.48 
 
160.67 
 
164.85 
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PREPARED MICROSPHERES BY ORIFICE-IONIC GELATION METHOD: 
 
         The microspheres prepared by the orifice-ionic gelation method were shown in  
         figure 8.13 
 
                           
                Figure 8.13: Prepared microspheres by orifice –ionic gelation method 
 
8.2. EVALUATION OF METRONIDAZOLE LOADED 
MUCOADHESIVE MICROSPHERES 
 Percentage yield 
 
 Size analysis 
 
 Drug content estimation and Encapsulation efficiency 
 
 Percentage moisture content 
 
 Scanning electron microscopy 
 
 In vitro wash –off test for Mucoadhesion 
 
 In vitro drug release studies 
 
8.2.1. Percentage yield 
The total amount of microspheres obtained were weighed and evaluated 
for percentage yield was represented in Table 8.11 and shown in figure 8.14. 
.From this, formulation F9 showed maximum percentage yield among the 
formulations were prepared. 
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                            Table 8.11: Percentage yield of all microspheres formulations 
 
 
S. No Formulation Code Percentage yield (%) 
1. F1 75.19 
2 F2 77.40 
3 F3 73.20 
4 F4 82.20 
5 F5 82.00 
6 F6 71.60 
7 F7 65.60 
8 F8 87.95 
9 F9 88.65 
 
 
 
 
                Figure 8.14:Graphical representation of percentage yield 
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8.2.2. Particle size determinations 
 
                                 Average particle size of microspheres was determined for all the   
formulations by sieving method analysis by using standard sieves. All the values were 
represented in Table 8.12. From the values, the formulation f9 had given the less average 
particle size compared to all othr formulations.  
                                    Table 8.12: Average particle size of microspheres 
 
S. No Formulations Average particle size      (µm) 
1 F1 649.38±1.14 
2 F2 693.18±0.44 
3 F3 720.64±2.54 
4 F4 738.28±0.81 
5 F5 760.58±1.36 
6 F6 794.56±1.94 
7 F7 660.85±2.77 
8 F8 690.48±0.34 
9 F9 642.38±1.14 
 
 
8.2.3. Drug content estimation and Entrpment efficiency 
 
 
Metronidazole microspheres (100 mg) from each batch were initially 
stirred in 3 ml  sodium  citrate  solution  (1%w/v)  until  it  completely  dissolved 
.7ml  of methanol   was added  to above  solution  to gel solubilize  calcium  
alginate  and further  solubilize Metronidazole. The filtrate was assayed for drug 
content by measuring the absorbance a t  276 nm after suitable dilution.  
Entrapment  e f f i c i e n c y  was  calculated using the formula. The drug content of 
microspheres were calculated for all the  formulations  (F1  to  F9)  and  
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represented  in  Table  8.13  also  shown  in  Figure 8.15. The formulation F9 was 
showed maximum drug content among the formulations were prepared 
 
Estimated % drug content in 
microspheres 
Encapsulation efficiency =                                                                               ×100 
 
Theoretical % drug content in 
microspheres 
                                     
                                    Table 8.13: Drug content and Entrapment efficiency 
 
 
 
 
 
 
        S. No 
 
 
 
Formulations 
 
Mean drug 
content 
(%) ± S.D∗ 
 
Entrapment efficiency 
 
(%) 
 
1 
 
F1 42.32±0.62 70.69 
 
2 
 
F2 36.34±1.46 71.96 
 
3 
 
F3 38.82±1.56 80.75 
 
4 
 
F4 40.62±1.38 83.66 
 
5 
 
F5 41.89±0.49 78.32 
 
6 
 
F6 39.64±2.26 84.68 
 
7 
 
F7 34.06±0.72 70.92 
 
8 
 
F8 32.92±1.86 77.62 
 
9 
 
F9 46.96±0.29 87.21 
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          Figure 8.15:Graphical representation of drug content and entrapment efficiency
 
 
8.2.4. Percentage moisture content 
 The percentage moisture content was calculated for all the formulations (F1 to F9) by 
using desiccator containing Calcium chloride at 37ºC for 24 hrs. The Final weight was 
determined and compared to initial weight .The values were represented in Table 8.13. 
                                                                                 
                                                                                w1 – w2 
                      Percentage   Moisture content =                     × 100 
                                                           w2 
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                         Table 8.14: Percentage moisture content of microspheres 
 
 
 
 
By comparing all the values of all formulations, formulation F9 was 
found to be the best one. The formulation F9 showed less moisture content. 
The order was F9<F8<F6<F7<F5<F4<F3<F2<F1. 
 
 
8.2.5. Scanning electron microscopy (SEM) 
 
 
The microspheres were observed under a scanning electron microscopy. 
The resolution of SEM instrument was 3 nm (30 KV HV Mode), 10 nm (30 
KV HV Mode), 40 nm (30 LV Mode) and a vacuum system is fitted to it. The 
shape of the Metronidazole microspheres was evidenced from the Scanning 
Electron Microscopy was found to be spherical and uniformly distributed and 
was shown in Figure 8.16. 
 
 
 
S. No 
 
 
 
Formulations 
 
Percentage moisture content 
(% ± S.D) 
 
1 F1 8.723±0.144 
 
2 F2 7.637±0.078 
 
3 F3 5.876±0.080 
 
4 F4 4.158±0.121 
 
5 F5 3.529±0.050 
 
6 F6 3.069±0.132 
 
7 F7 2.516±0.040 
 
8 F8 1.944±0.130 
 
9 
 
F9 1.116±0.138 
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Figure 8.16: Scanning electron microscopy of  Metronidazole loaded 
sodium alginate and methyle cellulose 
 
 
 
8.2.6. In vitro wash off test for Mucoadhesion 
  
 
The  wash  off  test  for  Mucoadhesion  for  all  formulations  (F1  to  F9)  
were represented in Table 8.15  
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Table 8.15: Data of in- vitro wash off test to assess mucoadhesive properties of           
                      microspheres 
 
 
Formulations 
 
1 hr 
 
2 hr 
 
4 hr 
 
6 hr 
 
8 hr 
 
               F1 
 
96.07 
 
88.79 
 
68.34 
 
56.45 
 
40.08 
 
F2 
 
94.74 
 
84.21 
 
78.92 
 
60.96 
 
41.16 
 
F3 
 
98.19 
 
80.32 
 
76.49 
 
66.46 
 
46.36 
 
F4 
 
98.52 
 
86.41 
 
72.37 
 
58.37 
 
44.29 
 
F5 
 
96.63 
 
82.62 
 
76.59 
 
54.38 
 
52.56 
 
F6 
 
97.42 
 
90.35 
 
82.72 
 
66.74 
 
54.84 
 
F7 
 
98.27 
 
88.53 
 
82.49 
 
64.36 
 
44.19 
 
F8 
 
96.86 
 
90.81 
 
78.67 
 
58.49 
 
42.28 
 
F9 
 
99.84 
 
97.68 
 
92.48 
 
84.39 
 
62.18 
 
Microspheres with a coat consisting of alginate and a mucoadhesive polymer exhibited 
good mucoadhesive properties in the in- vitro wash off test. The wash off test was faster 
at a pH 1.2 (stomach pH). It was observed that the pH of the medium was critical for the 
degree of hydration, solubility and mucoadhesion of the polymers. 
 
The results of the wash off test indicated that the formulation F9 had very good 
mucoadhesive properties with more than 62.18% retention for 8 hrs in  pH 1.2. 
 
Mucoadhesive microspheres of Metronidazole Results and  Discussion 
 
Adhiparasakthi college of pharmacy, Melmaruvathur. Page 103 
 
8.2.7. In vitro drug release studies 
               Table.8.16: Data of in vitro drug  released profile of  Metronidazole loaded mucoadhesive microspheres*   
S. No Time in hours Formulations  
F1 F2 F3 F4 F5 F6 F7 F8 F9 
 
1 
 
1 13.89±0.11 10.68± 1.54 17.42 ±1.04 11.58 ±1.54 15.46 ±1.56 12.65 ±0.45 18.35± 2.78 16.93±0.45 19.84±1.54 
 
2 
 
2 23.36±1.23 16.98± 1.89 21.54±2.66 17.29±0.61 19.75±1.05 20.67±0.15 25.90±1.96 22.76±0.55 26.72±1.45 
 
3 
 
3 29.07±1.54 25.37±0.54 27.65±0.20 21.45±0.02 23.67±1.51 26.74±1.63 30.05±0.12 28.23±0.56 31.36±1.52 
 
4 
 
4 36.64±1.56 32.46±1.65 31.56±1.53 28.87±0.91 29.56±1.55 33.45±1.55 39.45±0.56 35.98±0.22 38.43±0.01 
 
5 
 
5 42.34±0.57 45.36±0.22 39.78±1.01 35.47±0.78 34.78±0.45 39.87±1.23 44.89±1.56 41.87±1.51 46.64±0.12 
6  6 49.07±0.23 47.48±0.55 48.97±0.50 41.68±0.51 40.56±0.61 43.75±1.25 52.98±3.45 48.24±1.02 51.28±0.65 
 
7 7 53.03±1.54 50.67±0.23 51.87±1.21 48.89±0.05 46.78±0.49   49.56±0.61 59.56±1.56 52.76±2.55 57.14±0.54 
 
8 
 
8 61.96±1.45 56.89±1.55 58.16±0.54 52.98±0.07 54.81±0.61 53.23±0.74 64.87±1.26 59.56±2.16 66.49±1.55 
 
9 
 
9 66.76±0.77 61.87±0.54 64.89±0.26 59.89±   0.07 63.46±1.54 65.56±0.07 69.90±0.16 67.87±2.55 72.38±0.65 
 
10 
 
10 69.26 ±0.54 65.08±1.54 71.08±0.50 63.47±0.52 67.89±0.91 70.45±0.21 74.13±1.51 76.12±1.16 81.76±0.55 
                                                                 *All values are expressed as mean ± S.D. n=3 
 
                                    All in vitro drug release values were represented in Table 8.16 and shown in figures 8.17 to 8.26.
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Figure 8.17 : In vitro drug released curve of formulation F1 
 
 
 
 
 
                     
Figure 8.18 : In vitro drug  released curve of formulation F2 
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Figure 8.19: In vitro drug  released curve of formulation F3 
 
 
 
 
 
 
 
Figure 8.20 : In vitro drug  released curve of formulation F4 
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Figure 8.21 : In vitro drug  released curve of formulation F5 
 
 
 
 
 
Figure 8.22 : In vitro drug  released curve of formulation F6 
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Figure 8.23 : In vitro drug  released curve of formulation F7 
 
 
 
 
Figure 8.24 : In vitro drug  released curve of formulation F8 
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                     Figure 8.25 : In vitro drug  released curve of formulation F9 
 
 
 
 
         
 Figure 8.26 : plot for Comparision of in- vitro drug released for formulations F1 to F9 
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  8.2.8. Kinetics of Drug release 
 
 
The kinetics of In-vitro drug release was determined by applying 
the drug released data to various kinetic models such as zero order, first 
order, Higuchi and Korsmeyer- Peppas. The result obtained was represented 
in Table 8.17 and shown in Figure 8.27, 8.28, 8.29, 8.30, 8.31, 8.32, 8.33, 
8.34 and 8.35. 
Table 8.17:  In vitro drug released kinetics studies of all formulations 
 
 
 
Formulatio
n code 
Zero 
order 
R2 
First 
order 
R2 
 
 
 
Higuchi 
 
R2 
Korresmayer 
Peppas 
 
Best fit 
model 
 
 
R2 
 
 
n 
F1 0.9621 0.9501 0.9723 0.9908 0.432 Peppas 
F2 0.9650 0.9705 0.9663 0.9909 0.456 Peppas 
F3 0.9900 0.9471 0.9530 0.9985 0.402 Peppas 
F4 0.9503 0.8439 0.9782 0.9908 0.485 Peppas 
F5 0.9592 0.8811 0.9729 0.9903 0.365 Peppas 
F6 0.9622 0.9307 0.9684 0.9903 0.462 Peppas 
F7 0.9540 0.8611 0.9770 0.9901 0.398 Peppas 
F8 0.9597 0.9162 0.9756 0.9907 0.441 Peppas 
F9 0.9647 0.9609 0.9663 0.9907 0.356 Peppas 
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                Figure 8.27:  Best fit model (korsemeyer peppas) of formulation F1 
 
 
 
 
 
 
 
 
 
 
Figure 8.28:  Best fit model (korsemeyer peppas) of formulation F2 
 
 
 
 
 
 
               
 
 
               Figure 8.29:  Best fit model (korsemeyer peppas) of formulation F3 
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Figure 8.30:  Best fit model (korsemeyer peppas) of formulation F4 
 
 
Figure 8.31:  Best fit model (korsemeyer peppas) of formulation F5 
 
 
Figure 8.32:  Best fit model (korsemeyer peppas) of formulation F6 
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Figure 8.33:  Best fit model (korsemeyer peppas) of formulation F7 
              
             Figure 8.34:  Best fit model (korsemeyer peppas) of formulation F8 
             
            Figure 8.35:  Best fit model (korsemeyer peppas) of formulation F9 
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8.3. STABILITY STUDIES 
 
The formulation F9 was observed after specified period stability 
studies as per ICH guidelines .The formulations was monitored for drug 
content and In-Vitro drug released  profile  and  results  were  represented  in  
Table  8.17  and  percentage  drug released profile was shown  
 
Table 8.18: Data of stability studies of formulation (F9) 
 
 
 
Characteristics 
 
Initials* 
 
1 month* 
 
2 month* 
 
3 month* 
 
Drug content (%) 
 
46.96±0.29 
 
46.54±0.18 
 
46.34±0.38 
 
45.99±0.07 
 
In-vitro drug 
released 
 
 
81.76 
 
 
81.26 
 
 
81.12 
 
 
81.04 
*All the values are expressed as mean± S.D., n=3 
 
  Accelerated Testing: Accelerated temperature: 40° C ±2° C at 75% RH±5% for 3 
Months 
              
                                  Figure8.36:Graphical representation of stability study
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9. SUMMARY AND CONCLUSION 
 
 
 
          The goal of any drug delivery system was to provide the therapeutic amount of 
drug to the proper site in the body also to achieve and maintain the desired drug 
concentration in blood. Improving the therapeutic efficacy of existing drugs has 
been tried by different technologies. One of the effective technologies exiting in 
recent years of pharmacy is Microspheres. 
Mucoadhesive drug delivery system was developed in pharmacy field and drug 
retention for a prolonged time has been achieved. Hence, it was made an 
effective attempt to formulate the mucoadhesive microspheres by using Metronidazole 
as the model drug it possess the mean half life of six hours and bioavailability was 
found to be only 60%. Hence, it was chosen as the good candidate for the 
mucoadhesive microspheres in order to improve the bioavailability and prolong period 
of drug released. 
The identification of the drug was done by the FTIR spectroscopy analysis and 
drug polymers interaction was studied by DSC studies. It was concluded that no 
interaction was found between the Metronidazole and polymers. 
Mucoadhesive microspheres of Metronidazole were prepared by Orifice- ionic 
gelation method. Metronidazole mucoadhesive microspheres were composed of 
sodium alginate alone and in combination with HPMC and methyle cellulose. For 
first three formulations F1, F2 and F3 sodiumalginate alone and F4, F5 and F6 were 
composed sodium alginate and HPMC and F7, F8 and F9 were composed of sodium 
alginate and methyle cellulose. All the formulations were evaluated for the particle 
size, percentage yield, drug content and encapsulation efficiency, percentage moisture 
content, SEM analysis, in vitro wash off test, in vitro drug released and stability 
Mucoadhesive microspheres of Metronidazole Summary and Conclusion 
Adhiparasakthi college of pharmacy, Melmaruvathur. Page 116 
 
studies. 
          The higher drug content and encapsulation efficiency was observed as the 
concentration of alginate increased. This may be attributed to the greater 
availability of active calcium-binding sites in the polymeric chains and consequently 
the greater degree of cross linking as the quantity of sodium alginate increased 
resulting in the formation of nonporous microspheres. The drug loading efficiency 
greatly improved when alginate was blended with methyle cellulose at 1% level.  
        The wash of test were carried out in pH 1.2   Mucoadhesive property of 
formulation F9 consisting of sodium alginate3.5% along with methylcellulose 1% 
exhibited good mucoadhesive property.  
            The particle size analysis was carried out by sieving method The particle size 
ranges from 642.38±1.14µm to 794.56±1.94µm.  The percentage yield were found to 
be in range of 65.60% to 88.65%  and The percentage moisture content were found to 
be in range of 1.116±0.318% to 8.723±0.144%. 
           The in vitro drug release studies were carried out in the pH 1.2. The 
microspheres were prepared by ionic orifice gelation technique using calcium chloride 
as cross-linking agent. The microspheres cross-linked with calcium showed delay in 
disintegration and consequently a slow release of drug was obtained. To retared  the 
drug released  from the microspheres, HPMC and methyle cellulose were blended 
with the sodium alginate matrix. 
           This kind of release was the characteristics of swelling-controlled system in 
which the rate of solvent uptake into a polymer was largely determined by the rate of 
swelling and relax-action of the polymer chains. It was assumed that the drug 
molecules diffused out through a dissolving gel-like layer formed around the drug 
during the dissolving process.  
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                 On comparing the major criteria in evaluation such as drug content, 
encapsulation efficiency, in vitro wash off test and in vitro drug release characteristics, 
the formulation F9 was selected as the best formulation, as it showed the drug 
content as 46.96% and encapsulation efficiency was 87.21%, showed a good 
mucoadhesive nature in the in vitro wash off test was nearly 62.18% up to 8 hrs and   
in vitro drug released 81.76% up to 10 hrs. Based on all the above evaluation 
parameters it was concluded that the formulation F9 was found to be best 
formulation among the formulations F1 to F9 were prepared. The mechanism of drug 
released was calculated by applying the kinetic models and it was concluded that the 
formulations F9 follows the Korsmeyer – Peppas model and it undergoes Fickian 
diffusion mechanism (n≥0.5). 
               According to the stability studies, the formulation F9 was found to be stable 
up to   3 months of storage period in drug content and in vitro drug released profile. 
 
The formulations F9 was concluded best formulation among the 
formulations were prepared. 
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                               10. FUTURE PROSPECTUS                                    
   
              
  In this present work, Physio-Chemical characterization and in vitro 
evaluation of Metronidazole Mucoadhesive microspheres were performed. 
 
The following work had to perform in future: 
 
     The microspheres can be also formulated by using other different     
mucoadhesive polymers. 
     The mucoadhesive microspheres can also be formulated for advanced  
drug delivery other than oral administration. 
  In vivo and in vitro correlation studies had yet to be performed and the results has to     
be determined .From the correlation results, it can serve as the model for    
humans and gain a better understanding of drug absorption and its dependence in vitro 
drugrelease.
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